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Abstract 
 
Voltage-gated Ca
2+
 channels (VGCCs) are essential for initiating and regulating cardiac 
function. During the cardiac action potential, Ca
2+
 influx through L-type channels triggers 
the sarcoplasmic reticulum Ca
2+
 release that enables the EC coupling. Ca
2+
 can also enter 
cardiac myocytes through low-voltage-activated T-type channels, which are expressed 
throughout cardiac development until the end of the neonatal period, and can contribute to 
pacemaker activity as well as EC coupling to some extent. Importantly, T-type channels 
are re-expressed in ventricular myocytes under diverse pathological conditions such as 
ischemia or hypertrophy, suggesting that they play a role in cardiac disease.  
In a first part of this study, we examined the effects of VGCC blockers on the 
homeostasis and viability of primary cultures of cardiac myocytes (CMs), because of the 
importance of apoptosis and necrosis in cardiac disease. In a second part, we analyzed the 
cell mechanisms unleashed by hypoxic and hypertrophic stimuli, the involvement of 
VGCCs and the putative cytoprotective effects of VGCC blockade. Our results show that 
L-type and T-type channel blockers induce a low-level and transient ER stress, albeit with 
a distinct conveyance into cell macroautophagy and viability: whereas L-type channel 
blockers trigger a macroautophagic process in CMs, ultimately promoting apoptosis, T-
type channel blockers exert the opposite effect, by decreasing the autophagic flux and not 
affecting cell death. Furthermore, the blockade of T-type channels reduces Beclin1-
dependent autophagy and protects CMs subject to hypoxia-reoxygenation (as an in vitro 
paradigm for ischemia-reperfusion). With respect to the effect of hypertrophic insults, the 
results attained draw a complex scenario in which the cardiomyocytes constitutive 
macroautophagy is inhibited, giving way to alternative forms of protein degradation.  
In summary, we identify L-type and T-type channels as new targets for macroautophagy 
regulation of CMs, and provide new clues to the beneficial actions reported in clinical 
trials for T-type channel blockers, particularly against pathophysiological conditions 
involving a maladaptive autophagy.  
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Resumen 
 
Los canales de calcio voltaje-dependientes (CCDV) son esenciales para iniciar y regular 
la función cardíaca.Durante el potencial de acción cardíaco, el influjo de Ca
2+
 a través de 
los canales de tipo L desencadena la liberación de Ca
2+
 del retículo sarcoplasmático 
necesaria para el excitación-contracción (EC). El Ca
2+
 también puede entrar en los 
miocitos a través de canales de Ca
2+
 de bajo umbral o tipo T, que se expresan a lo largo 
del desarrollo cardíaco hasta el final del período neonatal, y pueden contribuir a la 
actividad marcapasos así como al acoplamiento EC. De forma destacable, los canales de 
tipo T se re-expresan en cardiomiocitos ventriculares bajo diversas condiciones 
patológicas incluyendo la isquemia y la hipertrofia, sugiriendo que juegan un rol relevane 
en la enfermedad cardíaca. 
 En una primera parte de este estudio, examinamos los efectos de los bloqueantes de 
CCDV sobre la viabilidad y la homeostasis de cultivos primarios de cardiomiocitos 
(CMs), debido a la importancia de la apoptosis y la necrosis en la enfermedad cardíaca. 
En una segunda parte, analizamos los mecanismos celulares desencadenados por 
estímulos de hipoxia e hipertrofia, así como la implicación de los CCDV y los posibles 
efectos citoprotectores debidos al bloqueo de los CCDV. Nuestros resultados muestran 
que los bloqueantes de canales de tipo L y T inducen un estrés de retículo de bajo nivel y 
transitorio, aunque divergiendo en lo que respecta la viabilidad celular: mientras que los 
bloqueantes de canales de tipo L exacerban la macroautofagia, provocando la muerte 
celular, los bloqueantes de canales de tipo T reducen el flujo autofágico y no afectan 
negativamente a la viabilidad de los CMs. Adicionalmente, el bloqueo de los canales de 
tipo T reduce la autofagia dependiente de Beclin1 y protege a los CMs  tratados con  
hipoxia-reoxigenación (un paradigma in vitro de la isquemia-reperfusión). Con respecto 
al efecto de la estimulación hipertrófica, los resultados conseguidos perfilan un escenario 
complejo en el que la macroautofagia constitutiva de los cardiomiocitos es inhibida, 
dando paso a formas alternativas de degradación proteica. 
En conclusión, en este estudio hemos identificado a los canales de tipo L y T como 
nuevas dianas para la regulación de la autofagia en CMs, y obtenido datos novedosos 
sobre las acciones beneficiosas de los bloqueantes de canales de tipo T descritas en 
esayos clínicos, particularmente frente a condiciones patofisiológicas que implican una 
autofagia maladaptativa. 
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Els canals de calci dependents de voltatge (CCDV) són essencials per a iniciar i regular la 
funció cardíaca.Durant el potencial d'acció cardíac, l'influx de Ca
2+
 a través dels canals de 
tipus L desencadena l'alliberament de Ca
2+
 del reticle sarcoplasmàtic necessària per 
l'acoblament E-C. El Ca
2+
 també pot entrar en els miòcits a través de canals de Ca
2+
 de  
tipus T, que s'expréssen durant el desenvolupament cardíac fins el final del període 
neonatal, i poden contribuïr a l'activitat marcapassos així com a l'acoblament EC. De 
forma destacable, els canals de tipus T es re-expréssen als cardiomiòcits ventriculars en 
diverses condicions patològiques com la isquèmia i  la hipertròfia, el què suggereix que 
juguen un rol relevant en l'enfermetat cardíaca.  
En una primera part d'aquest estudi, vàrem examinar els efectes dels bloquejants de 
CCDV sobre l'homeostasi i la viabilitat de cultius primaris de cardiomiòcits (CMs), degut 
a la importància de l'apoptosi i la necrosi en l'enfermetat cardíaca. En una segona part, 
vàrem analitzar els mecanismes cel·lulars desencadenats per estímuls d'hipòxia i 
d'hipertròfia, així com l'implicació dels CCDV i els possibles efectes citoprotectors 
deguts al bloqueig dels CCDV. Els resultats obtinguts mostren que els bloquejants de 
canals de tipus L i T indueixen un estrés de reticle de baix nivell i transitori, però que 
divergeixem pel què fa al seu efecte sobre la viabilitat celular: mentre que els bloquejants 
de canals de tipus L exacerben  la macroautofàgia, provocant la mort cel·lular, els 
bloquejants de canals de tipus T redueixen el flux autofàgic i no afecten negativament la 
viabilitat dels CMs. Addicionalment, el bloqueig dels canals de tipus T redueix l' 
autofàgia dependent de Beclin1 i protegeix els CMs  tractats amb  hipòxia-reoxigenació 
(un paradigma in vitro de l'isquèmia-reperfusió). Respecte l’efecte de l’estimulació 
hipertròfica, els resultats assolits perfilen un escenari complex en el que la 
macroautofàgia constitutiva dels cardiomiòcits és inhibida, donant pas a formes 
alternatives de degradació proteica. 
En definitiva, en aquets estudi hem identificat els canals de tipus L i T com a noves 
dianes per la regulació de l'autofàgia en CMs, i obtingut dades novedoses sobre les 
accions beneficioses dels bloquejants de canals de tipus T descrites en assaigs clínics, 
particularment front patologies que impliquen una autofàgia maladaptativa. 
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1. Introduction:  
 
Over the past decade, cardiovascular diseases are among the leading causes of mortality 
globally. According to the World Health Organization, about 17.3 million people died in 
2008 due to cardiac disease, representing 30% of global deaths 
1
. The end result of many 
forms of cardiovascular disease is heart failure, a syndrome where the heart is unable to 
meet the metabolic demands of the body. Heart failure accompanied by cardiac 
remodelling induced by several factors such as cardiac hypertrophy, apoptosis, etc., lead 
to abnormalities of impulse conduction and arrhythmias. Heart failure can be described as 
a pathologic process characterized by a decrease of contractility and consequent decline 
of cardiac output, which involves a complex set of changes like inflammatory cytokines, 
endothelin, angiotensin II, and aldosterone which reprogram the cardiac muscle at the 
cellular and molecular levels 
2
.  
Since the finding of Ringer in 1880s 
3
 proved that ionic calcium (Ca
2+
) is essential for the 
contractility of the heart, it became apparent that Ca
2+
 homeostasis is certainly involved in 
the function of both normal and failing hearts. Much attention has been paid to the 
understanding of the role of Ca
2+
 regulation in heart failure 
4
. Entry of Ca
2+
 in the cells is 
responsible for the excitation-contraction (E-C) coupling and, in addition, Ca
2+
 influx 
regulates the pacemaking activity and atrio-ventricular conduction of the hearts 
5
. The 
influx of Ca
2+ 
ions into the cells is facilitated by voltage gated Ca
2+
 channels (VGCC). 
Cytosolic Ca
2+
 binding proteins respond to the increased Ca
2+
 levels by altering the cell 
function and, after the signaling is over, Ca
2+
 is expelled from the cell through different 
active transporters placed in the plasma membrane, or actively internalized in intracellular 
stores. The endoplasmic reticulum (ER) is the most important Ca
2+
 storage site. 
Relevantly, the high luminal Ca
2+
 concentration in the ER is critical for determining the 
protein synthesis process within the ER. For this reason, any disturbance in the cellular 
Ca
2+
 homeostasis triggers the so called ER stress, which often leads to the activation of 
the Unfolded Protein Response (UPR). The UPR is an adaptive pool of molecular 
mechanisms designed to restore homeostasis. One of the possible outcomes of a sustained 
UPR is the induction of macroautophagy. 
Although the role of ER stress and autophagy in cardiac remodeling and 
cardiomyopathies has been studied extensively, no link has been established between 
between VGCCs and UPR or autophagy. Would this link exist, VGCC pharmacological 
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modulators could be used as a potential therapeutic strategy in the treatment of 
cardiomyopathy. Thus it becomes necessary to understand the function of VGCCs in the 
calcium signaling (beyond E-C contraction) in the heart. This thesis provides a number of 
different approaches to study the role of VGCCs in regulating the homeostasis of 
cardiomyocytes (CMs), leading to cell death or survival, thereby intending to establish the 
basis for a new therapeutic approach for cardiovascular diseases by pharmacologic or 
genetic modification of VGCCs. 
 
2. Heart:  
 
2.1.  Structure 
 
The cardiovascular system is the first system to develop and function in an animal. The 
heart, located in the thoracic cavity between the lungs, is a hollow muscular organ, 
responsible for pumping blood through the blood vessels by repeated, rhythmic 
contractions. It is surrounded by a thick, membranous sac called Pericardium that protects 
and lubricates the heart. Pericardium is composed of striated involuntary muscles that 
produce electric impulses that cause the heart to contract, pumping the blood throughout 
the body (Figure 1)
6
. 
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Figure 1: Diagrammatic section of the heart. The arrows indicate the direction of blood 
flow. (Adapted from Vander et al. Human Physiology 2003) 
 
The human heart has two chambers, the atria and the ventricles. There are two atria on 
either side of the heart. The right atrium receives de-oxygenated blood from the superior 
and inferior vena cava and the left atrium receives oxygenated blood from the left and 
right pulmonary veins. The ventricles collect blood from the atrium to be pumped out of 
the heart. The right ventricle pumps blood into the pulmonary circulation for the lungs 
and the left ventricle pumps blood into the systemic circulation for the rest of the body. 
The two ventricles are separated by a thick muscular wall called septum. Blood flows 
from the right atrium to the right ventricle through the tricuspid valve and is pumped out 
of the pulmonary semilunar valve to the lungs through the pulmonary artery. The 
oxygenated blood flows back to the left atrium via pulmonary veins. The blood from the 
left atrium flows to the left ventricle through the mitral valve, and again it is pumped 
through the aortic semilunar valve to the rest of the body through aorta. The 
deoxygenated blood returns to the heart through inferior and superior vena cavae and 
flows through the right atrium, where the process of oxygenation of blood begins again
6
. 
 
2.2. Physiology of heart: 
 
The myocardium is the muscular tissue of the heart. The cardiac muscle cells are striated 
as the result of an arrangement of thick myosin and thin actin filaments similar to that of 
skeletal muscle. The individual cardiac muscle cells are separated by intercalated discs. 
The cardiac muscle is self-exciting and it has its own conduction system. This is in 
contrast with skeletal muscle, which requires either conscious or reflex nervous stimuli. 
The heart’s rhythmic contractions occur spontaneously, although the frequency or the 
heart rate can be changed by nervous or hormonal influence such as exercise or the 
perception of danger.  
The cardiac muscle is of three major types namely, atrial muscle, ventricular muscle and 
specialized excitatory and conductive muscle fibers. The atrial and ventricular cardiac 
muscles contract in the same way as skeletal muscle, except that the duration of 
contraction is much longer. Conversely, the specialized excitatory and conductive fibers 
contract feebly because of the presence of few contractile fibrils, instead, they exhibit 
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either automatic rhythmical electrical discharge in the form of action potentials or 
conduction of the action potentials through the heart, providing an excitatory system that 
controls the rhythmical beating of the heart.  
 
2.3. Excitation-contraction coupling: 
 
The term excitation-contraction coupling refers to the mechanism by which the action 
potential causes the myofibrils of muscle to contract. This mechanism is facilitated by an 
increase in the cell’s cytosolic Ca2+ concentration. Like in skeletal muscle, the increase in 
cytosolic Ca
2+
 concentration in cardiac muscle is mainly due to the release of Ca
2+
 from 
the sarcoplasmic reticulum. The depolarization of the sarcolemma intiates the opening of 
the L-type Ca
2+
 channels (dihydropyridine receptors, DHRPs) located in the sarcolemma 
leading to the influx of Ca
2+
 ions through DHRPs. This Ca
2+
 combines with the regulator 
protein troponin and cross-bridge formation between actin and myosin is initiated.  
                            
Figure 2: Excitation-contraction coupling in cardiac muscle. Depolarization of the 
plasma membrane allows the flow of Ca
2+
 into the cytosol by opening the VGCC. This 
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increase of Ca
2+
 in the cytosol triggers the contraction of the cell by mediating various 
processes. (Adapted from Vander et al. Human Physiology 2003) 
 
In the cardiac muscle the action potential opens voltage-sensitive Ca
2+
 channels in the T-
tubule membranes; then Ca
2+
 diffuses from the extracellular fluid through these channels 
into the cells, causing a small increase in the concentration of Ca
2+
 in the region 
immediately adjacent to the sarcoplasmic reticulum (SR) (Figure 2). This small increase 
in Ca
2+
 concentration facilitates Ca
2+
 binding to Ca
2+
 receptors on the external surface of 
the sarcoplasmic reticulum membranes (the ryanodine receptors). These Ca
2+
-sensitive 
receptors contain intrinsic Ca
2+
 channels, and activation of the receptors opens the 
channels, allowing a large net diffusion of Ca
2+
 from the Ca
2+
-rich interior of the 
sarcoplasmic reticulum into the cytosol (this is termed “Ca2+-induced Ca2+ release”). It is 
mainly this Ca
2+
 that causes the contraction. Thus, even though most of the Ca
2+
 causing 
contraction comes from the sarcoplasmic reticulum, the process unlike that in skeletal 
muscle is dependent on the movement of extracellular Ca
2+
 into the muscle, the Ca
2+
 then 
acting as the signal for release of the sarcoplasmic reticulum Ca
2+
. Contraction ends when 
the cytosolic Ca
2+
 concentration is restored to its original extremely low value by active 
transport of Ca
2+
 back into the sarcoplasmic reticulum. Also, an amount of Ca
2+
 equal to 
the small amount that had entered the cell from the extracellular fluid during excitation is 
transported out of the cell, so that the total cellular Ca
2+
 content remains constant. The 
transport into the sarcoplasmic reticulum is by primary active Ca
2+
-ATPase pumps; the 
transport across the plasma membrane is also by Ca
2+
-ATPase pumps plus Ca
2+
/Na+ 
exchangers. The amount that cytosolic Ca
2+
 concentration increases during excitation is a 
major determinant of the strength of cardiac muscle contraction 
7-10
.  
 
3. Voltage-Gated Calcium Channels (VGCC): 
 
3.1. Introduction 
 
VGCC channels play a crucial role in transducing changes in membrane potential into 
intracellular Ca
2+
 transients. These intracellular Ca
2+
 transients signal to initiate various 
physiological processes like neurotransmitter release, cell contraction, ion transport, cell 
proliferation and growth, in a diversity of cell types
7
. However, a signaling role for 
VGCCs (in addition to its role in EC-coupling) in muscle cells is largely unknown. Figure 
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3 schematically explains the initiation of various cellular processes upon Ca
2+
 entry via 
VGCC. 
 
             
 
Figure 3: Signal transduction by VGCC. Calcium influx through the voltage gated Ca
2+
 
channels initiates various intracellular processes like contraction, protein phosporylation 
and dephosporylation, secretion, synaptic transmission and enzyme regulation. Inset in 
the plasma membrane shows the Subunit complex structure of VGCC. (Catterall W.A, 
2011-Adapted from Takahashi et al. 1987) 
 
 
L-type VGCCs, as purified from skeletal muscle transverse tubules are complex 
structures formed of 5 subunits that are termed as α1, α2, β, γ and δ subunits. The α1 
subunit or the pore-forming α subunit is a transmembrane structure with a length of 2000 
amino acid residues and a molecular weight of 190 kDa. The α1 subunit is associated 
with α2δ dimer of 170 kDa through a disulfide linkage, an intracellular phosphorylated β 
subunit of 55 kDa and a transmembrane γ subunit of 33 kDa forming a large 
macromolecular complex. In the following subtopics, the structure and functions of each 
subunits of VGCC such α1, α
2
/δ, β and γ, will be described in more detail. 
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3.2. Structure and functions of VGCC subunits: 
 
3.2.1. α1 subunit: 
 
The α1 subunit or the Cavα1 is a 190-250 kDa protein formed of four homologous repeats 
(I-IV) connected through cytoplasmic loops. Each repeat contains six predicted 
transmembrane segments (S1-S6) and a pore-forming loop (P-loop) between S5 and S6. 
These four P-loops are essential for calcium conductance. The voltage-dependent 
movement of Ca
2+
 is facilitated by a voltage sensor that comprises S6 and S4 segments, 
which in turn facilitate the opening and closing of these channels. The α1 subunit appears 
to be capable of forming a functional calcium channel on its own and hence all the other 
subunits are sometimes referred to as auxillary or anxillary subunits, yet these channels 
affect largely the channel gating and expression. The expression of multiple forms of α1 
subunit gives rise to diversity of calcium channels that are isolated by molecular cloning 
8-14
. 
 
3.2.2. β subunit: 
 
In their native state, all the high voltage activated calcium channels appear to contain β 
subunits. The β subunit bind to α- interaction domain, AID between the transmembrane 
domains I and II of the pore-forming α-1 subunit and affects the multiple channels 
properties such as voltage-dependent activation, inactivation rates, G-protein modulation, 
drug sensitivity and cell surface expression 
15. These β subunits are peripheral membrane 
proteins associated with the cytoplasmic aspect of the surface membrane with a molecular 
weight of  55-60 kDa 16. β subunits plays several important functions within the VGCC 
complex: a) they serve a key role in targeting the calcium channel subunits complex, b) 
they are regulated by protein kinases, c) they act as key modulators of the gating and 
pharmacological properties of α1 subunits.  
Four isoforms of β subunit namely β1- β4 are known to exist in mammals 17. Each of the 
β subunits appears able to partner with each of the α
1 
subunits from high voltage-activated 
channels. The different β subunit isoform cause different shifts in voltage dependent 
gating; hence the association with different β subunit can result in the substantial change 
in the physiological functions of α
1 
subunit. 
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3.2.3. α2/δ subunits:  
 
The glycosylated proteins α
2 
and δ are linked together by disulfide bonds to form a dimer 
of molecular weight 175 kDa. The structure of α
2
δ subunit was first determined using 
biochemical studies on purified dihydropyridine receptors from skeletal muscles. The 
cDNA sequence obtained made it clear that both α
2 
and δ subunits are products of a single 
gene encoding the α
2
/δ pre-protein, which is cleaved into α
2 
and δ by post translational 
proteolytic process 
18. Four α
2
δ subunits have been cloned: α
2
δ -1, α
2
δ -2, α
2
δ- 3 and α
2
δ -
4. The α
2
δ subunits are reported to be GPI-anchored, which has implications for their 
intracellular trafficking and endocytosis. Although little structural information is available 
for α
2
δ subunits, it is well established that the 2 domain is completely extracellular, 
whereas the  domain contains a transmembrane sequence18. The α
2
δ subunits play an 
important role in enhancing the forward trafficking of the α1 Ca
2+
 channel subunits for 
high voltage-activated channels, and decrease their turnover at the plasma membrane 
19
.   
 
3.2.4. γ subunit: 
 
A fifth subunit, known as γ (25-38 kDa), has 4 transmembrane domains. Purification of 
cardiac Ca
2+
 channels labelled by dihydropyridine Ca
2+
 antagonists revealed subunits of 
α1, α2δ, β and γ subunits of skeletal muscle Ca
2+
 channels, whereas immunoprecipitation 
of neuronal Ca
2+
 channels labeled again by dihydropyridine Ca
2+
 antagonists identified 
α1, α2δ and β subunits, but no γ subunits. Similarly, purification and immunoprecipitation 
of brain membrane preparations also revealed α1, α2δ and β subunits, but no γ subunits. 
However, recent experiments have revealed the presence of a novel neuronal γ subunit, 
which serves to be a target of the stargazer mutation in mice. The stargazing-like γ 
subunits are also called as transmembrane AMPA receptor modulators, and are the 
primary modulators of glutamate receptors in the post synaptic membrane of brain 
neurons 
7,20
. In spite of all these studies, detailed information on physiological and 
structural role of the γ subunits and their association with voltage gated Ca2+ channels is 
yet to be determined.  
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3.3. Classification of Ca2+ channels: 
 
The first recordings of Ca
2+
 currents in CMs led way to the knowledge of multiple types 
of Ca
2+
 currents as defined by physiological and pharmacological criteria  
21-22
. Ca
2+
 
currents in cardiac smooth and skeletal muscles are distinguished by several factors such 
as single channel conductance, voltage-dependent activation and inactivation, marked 
upregulation by cAMP-dependent protein phosphorylation pathways and specific 
inhibition by Ca
2+
 channel antagonists including dihydropyridines, phenylalkylamines 
and benzothiazepines. The molecular cloning of VGCC subunits has paved way for an 
elaborate understanding of Ca
2+
 channel diversity. The considerable variation in the 
degree of depolarisation required to cause significant opening differentiates the voltage 
gated Ca
2+
 channels from one another. Based on this criterion, the voltage gated Ca
2+
 
channels are grouped as low voltage-activated (LVA) and high voltage-activated (HVA) 
channels. HVAs are activated at depolarized membrane potentials (around -40 mV), 
whereas LVAs are activated at negative membrane potentials closer to the typical cell 
resting membrane potentials (-80 mV to -60 mV). Figure 4 shows the phylogenetic 
representation of the primary sequence of Ca
2+
 channels. Further studies on 
pharmacological and physiological properties led to a specific classification of native 
channels as T-, L-, N-, P/Q- and R- type 
23-25
 (T-, L-, N-, P/Q- and R- type are described 
in more details in the below subtopics). L-type, R-type, N-type and P/Q type Ca
2+
 
channels are grouped under HVA Ca
2+
 channels and T-type Ca2+ channels are grouped 
under LVA Ca
2+
 channels  
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Figure 4:  Calcium channel dendrogram showing the percentage of identity between the 
different cloned calcium channels. (Modified from Catterall W.A, 2005) 
 
The pharmacology of the three subfamilies of Ca
2+
 channels is quite distinct. The L-type 
Ca
2+
 channels (Cav1 subfamily) are the molecular targets of the organic Ca
2+
 channel 
blockers used widely in the treatment of cardiovascular diseases. The L-type Ca
2+
 channel 
blockers include phenylalkylamines and dihydropyridines. The Cav2 subfamily of Ca
2+
 
channels that include P/Q, N and R-type, is relatively insensitive to dihydropyridine Ca
2+
 
channel blockers but they can be specifically blocked with high affinity by peptide toxins 
such as ω-Agatoxin and ω-Conotoxin 26.The T-type Ca2+ channels (Cav3) are insensitive 
to both dihydropyridines and known peptide toxins, except kurtoxin, a scorpion toxin 
known to inhibit Cav3.1 and Cav3.2 channel gating
27-28
. Mibefradil acts as a selective 
blocker for T-type as well as L-type Ca
2+
 currents 
29
. Table 1 summarizes the localization, 
function and also the antagonists of the HVA and LVA Ca
2+
 channels. 
 
Table 1: 
 
Current Channel Localization Specific 
antagonists 
Cellular 
functions 
Inherited 
diseases 
L Cav1.1 
(α1S) 
Skeletal 
muscles; 
Dihydropyridines; 
phenylalkylamine
Excitation-
contraction 
Hypokalemic 
periodic 
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transverse 
tubules 
s, 
benzothiazepines 
coupling paralysis 
 
Cav 1.2 
(α1C) 
Cardiomyocy
tes; smooth 
muscle 
myocytes; 
endocrine 
cells; 
neuronal cell 
bodies; 
proximal 
dendrites 
Dihydropyridines; 
phenylalkylamine
s, 
benzothiazepines 
Excitation-
contraction 
coupling; 
hormone 
release; 
regulation of 
transcription; 
sysnaptic 
integeration 
Timothy 
syndrome; 
cardiac 
arrhythmia with 
developmental 
abnormalities 
and autism 
spectrum 
disorders 
 
Cav 1.3 
(α1D) 
Endocrine 
cells; 
neuronal cell 
bodies and 
dendrites; 
cardiac atrial 
myocytes 
and 
pacemaker 
cells; 
cochlear hair 
cells 
Dihydropyridines; 
phenylalkylamine
s, 
benzothiazepines 
Hormone 
release; 
regulation of 
transcription; 
sysnaptic 
regulation; 
cardiac 
pacemaking; 
hearing; 
neurotransmitter 
release from 
sensory cells 
 
 
Cav 1.3 
(α1F) 
Retinal rod 
and bipolar 
cells; spinal 
cord; adrenal 
cells; mast 
cells 
Dihydropyridines; 
phenylalkylamine
s, 
benzothiazepines 
Neurotransmitte
r release from 
photoreceptor 
Stationary night 
blindness 
P/Q 
Cav 2.1 
(α1A) 
Nerve 
terminals and 
dendrites: 
neuroendocri
ne cells 
ω-Agatoxin IVA 
Neurotransmitte
r release; 
dendritic Ca
2+
 
transients; 
hormone release 
Familian 
hemiplegic 
migraine; 
cerebellar ataxia 
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N 
Cav 2.2 
(α1B) 
Nerve 
terminals and 
dendrites; 
neuroendocri
ne cells 
ω-Conotoxin-
GVIA 
Neurotransmitte
r release; 
dendritic Ca
2+
 
transients; 
hormone release 
 
R 
Cav 2.3 
(α1E) 
Neuronal cell 
bodies and 
dendrites SNX-482 
Repetitive 
firing; dendritic 
calcium 
transients; 
hormone release 
 
T 
Cav 3.1 
(α1G) 
Cardiac and 
smooth 
muscle 
myocytes; 
Neuronal cell 
bodies and 
dendrites 
None 
Pacemaking; 
repetitive firing 
 
 
Cav 3.2 
(α1H) 
Cardiac and 
smooth 
muscle 
myocytes; 
Neuronal cell 
bodies and 
dendrites 
None Pacemaking; 
repetitive firing 
Absence seizures 
 
Cav 3.3 
(α1I) 
Neuronal cell 
bodies and 
dendrites 
None Pacemaking; 
repetitive firing 
 
 
Table 1: Classification of VGCCs based on their cellular function and pharmacologic 
properties.Although various subtypes of calcium channels are identified in different cells, 
only a few of them are functionally expressed in CMs.  
 
3.4. Voltage-Gated Calcium Channels in CMs: 
 
The Ca
2+
 entry through the transmembrane voltage gated Ca
2+
 channels of excitable cells 
mediates a variety of biological functions like membrane excitability, cell cycle events, 
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enzyme regulation, muscle contraction, gene expression and hormone secretion. The L-
type Ca
2+
 channel is ubiquitous and is dominant in mature CMs, whereas the expression 
of T-type Ca
2+
 channels varies among species and cardiac tissues. Although it has been 
shown that T-type Ca
2+
 channels have a possible involvement in pacemaker activity of 
the heart, their precise functions remain unclear. 
The Ca
2+
 influx through L-type Ca
2+
 channels or the L-type Ca
2+
 current (ICa-L) largely 
determine the Action Potential (AP) amplitude and refractoriness in CMs as well as the 
automicity in sino-atrial cells. During action potential, ICaL activates contraction by 
triggering Ca
2+
 release from sarcoplasmic reticulum (SR) this in turn regulates E-C 
coupling 
30-31
.  
 
3.4.1. L-type Ca2+ channels: 
 
L-type Ca
2+
 channels serve as mediators of Ca
2+
 influx and the cascade of regulatory 
events accompanying it. They play a pivotal role in the function and dysfunction of 
ventricular CMs. L-type Ca
2+
 channels are multi-subunit complexes that interact with 
several molecules involved in the cardiac function, notably by -adrenergic signaling. 
The L-type Ca
2+
 channels incorporate the conduction pore, voltage sensor and gating 
apparatus and the known sites of channel regulation by second messengers, drugs and 
toxins. Two L-type channel isoforms, Cav1.2 and Cav1.3, are known to be present in 
CMs. The Cav1.2 gene encodes for the typical ICaL in ventricular myocytes 
32
. 
Experiments with knockout mice have proved that Cav1.2 knockout mice die during early 
embryonic development, from cardiovascular failure 
33
. Cav1.2 is organized into four 
homologous domains (I–IV), each consisting of six-transmembrane α helices (S1 through 
S6) and a membrane-associated P loop between S5 and S6. Two size forms of the Cav1.2 
subunit (240 and 210 kDa), are present in cardiac muscle and differ by truncation of the 
C-terminus by in vivo proteolytic processing. In ventricular CMs, the proteolytic fragment 
of Cav1.2 repressed its own transcription 
34
. In order to form a functional L-type Ca
2+
 
channel, this main and largest subunit co-assembles with auxiliary subunits in a 1:1:1 
ratio: an entirely intracellular β subunit and a disulphide-linked α2δ subunit complex, 
with the carboxy-terminal transmembrane segment of δ anchoring the extracellular α2 to 
Cav1.2 
35
. Cav1.3 produces currents endowed with a more negative activation threshold 
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and faster kinetics compared to classical ICaL. Cav1.3 is mainly expressed in 
atrioventricular and sinus nodes and also may play a role during development 
36
.  
 
3.4.2. T-type Ca2+ channels: 
 
The pharmacological and biophysical properties of T-type Ca
2+
 channels put them under 
the low voltage-activated channel class, which open at low membrane potentials and 
inactivate very rapidly. The T-type Ca
2+
 channels are composed of α1 subunits, which are 
the pore-forming subunits that determine most of the characteristics such as channel 
selectivity for Ca
2+
, voltage-dependent activation and the sensitivity to organic Ca
2+
 
channel blockers. Two isoforms of T-type Ca
2+
 channels are identified in the heart, 
namely Cav3.1 and Cav3.2. Both of these isoforms are functionally expressed in 
embryonic hearts, but are silenced during the development. Although Cav3.1 and Cav3.2 
have similar activation and inactivation kinetics, they can be differentiated by their 
recovery from inactivation and sensitivity to blockade by Ni
2+
. Recombinant Cav3.2 
currents are blocked by relatively low Ni
2+
 concentrations, while CaV3.1 currents are 
much less sensitive to Ni
2+
 
37
. It should be noted that recombinant Cav1 channels require 
auxiliary subunits for normal gating behavior, while CaV3.1 or CaV3.2 alone exhibits 
currents similar to native ICaT 
38
. Notably, the T-type Ca
2+
 channels are found to be re-
expressed in adult atrial and ventricular myocytes, under various pathological conditions 
such as hypertrophy and heart failure. During such pathological conditions these channels 
contribute to abnormal electrical activity and excitation-contraction coupling 
38-40
. It has 
also been shown that increased Ca
2+
 influx through Cav3.2 induces calcineurin/NFAT 
hypertrophic signaling 
41
. Thus both L-type and T-type Ca
2+
 channels (along with the 
auxillary subunits in combination with the former) play a significant role in the 
pathophysiology of the heart.   
 
3.5. Calcium signaling mediated by calcium binding proteins 
 
Ca
2+
 binding proteins play an important role in the regulation of cardiac-signal 
transduction as well as in cardiac contractility. These proteins sense the Ca
2+
 
concentration and bind specifically to signaling molecules, being involved in the 
establishment of signaling microdomains. The most prominent of Ca
2+
 binding proteins is 
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Calmodulin (CaM), which is a central mediator of Ca
2+
 dependent signaling, transducing 
local Ca
2+ 
signals into specific cellular outcomes. 
 
3.5.1. Calmodulin  
Calmodulin is composed of 148 amino acids and is found to exist in two different 
configurations namely apocalmodulin and Ca
2+-
calmodulin. Apocalmodulin lacks Ca
2+
 
whereas Ca
2+-
calmodulin binds with 4 Ca
2+
 ions per molecule- The shift from apo- to 
Ca
2+
 calmodulin involves substantial structural changes 
42
. There are different Ca
2+
 
Calmodulin dependent enzymes that play an important role in cardiac function. They are,  
 
a. CaMKII : 
 
One of the main functions of CaM is the regulation of ion channels by activating the 
Ca
2+
/CaM- sensitive enzymes such as CaMKII. If intracellular Ca
2+
 concentration rises, 
activated calmodulin (Ca
2+
/CaM) binds to CaMKII at the regulatory domain. Ca
2+
/CaM 
binding disrupts the association of the regulatory and catalytic domain, and causes a 
conformational shift exposing the catalytic domain for substrate binding and relieves 
autoinhibition. Figure 5 shows the regulation of CaMKII by CaM, where the oxidation 
and autophosphorylation converts CaMKII into Ca
2+
/CaM independent enzyme leading to 
many possible physiological and patophysiological outcomes 
43
.   
CaMKII is in fact a serine/threonine kinase which phosphorylates several proteins that 
play a key role in Ca
2+
 handling and E-C coupling, including ryanodine receptors (RyRs), 
phospholamban and the LTCC 
44
. CaMKII is known to be activated by high amplitude 
Ca
2+
 waves 
45
.  
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Figure 5: CaM in the regulation of CaMKII adapted from Erickson et al. Oxidation and 
autophosphorylation of CaMKII convert it into Ca
2+
/CaM independent enzyme leading to 
various arrhythmias. (Adapted from Erickson et al, 2011) 
 
CaMKII is sensitive to the frequency of Ca
2+
 transients and ideally responds to changes in 
cardiac rhythm, therefore providing an additional mode of Ca
2+ 
regulation. CaMKII 
regulation of Cav1.2 channels is a major contributor to the positive force-frequency 
relationship of cardiac contraction. Direct interaction of CaMKII with Cav1.2 is necessary 
for Ca
2+ 
dependent facilitation. CaMKII forms a complex with the cardiac Cav1.2 channel 
and the kinase activity is directly influenced by its interaction with 1C C terminus 46-47. 
CaMKII integrates Ca
2+
 signals to control myocyte excitability. Thus, CaMKII modulates 
ICaL, which may be important under pathophysiological conditions (e.g. arrhythmias). A 
transgenic mouse model of cardiac hypertrophy over-expressing CaMKIV showed an 
increase in CaMKII activity and also showed an increase in the propensity for ventricular 
arrhythmias, which has been attributed to increased activity of CaMKII resulting in 
enhanced opening frequency of L-type Ca channels
48
. 
T-type Ca
2+
 channels are expressed during cardiac development until the end of the 
neonatal period, then their expression decreases 
49
. Significant ICaT reappears in adult 
ventricular myocytes during the development of cardiac hypertrophy and failure 
50
. T-
type Ca
2+ 
channels are phosphorylated by CaMKII, which increases the probability of 
single channel openings and that is also upregulated in the ventricles during cardiac 
hypertrophy
51
. It has been speculated that the enhancement of ICaT in CMs may enhance 
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their autonomous activity contributing to arrhythmogenesis. However, the potential role 
of CaMKII signaling in the regulation of T-type Ca
2+
 channels has not been fully 
explored 
52
. 
It has also been proved that CaMKII is responsive to high amplitude Ca
2+
 waves mediated 
by activation of -adrenergic receptors. CaMKII activity is induced by heart failure, in 
turn inducing the activity of hypertrophic transcription factors NFAT and GATA4 
53-56
.   
 
b. Ryanodine receptors (RyR2): 
 
CaM also regulates the SR Ca
2+
-release channels, the ryanodine receptors (RyR2). 
Ryanodine receptors are proteins that trigger the release of most of the activator Ca
2+
 that 
mediates the final step in the E-C coupling. In the heart, RyR2 are localized within the 
sarcolemmal cisternae of the SR. Cardiac RyR2 are also present adjacent to plasma 
membrane Ca
2+
 channels. This facilitates spraying of a small amount of Ca
2+
 that enters 
via plasma membrane channels directly into intracellular release channels, thus resulting 
in the increase in cytosolic Ca
2+ 
concentration, termed as Ca
2+
 sparks. These Ca
2+
 sparks 
provide signals that open the RyRs. RyR2 then release a much larger amount of Ca
2+
 
from the SR, compared to the Ca
2+
 that entered the cell through the plasma membrane 
channels 
57
.  When Ca
2+
 binds to CaM, it displaces the autoinhibitory domain and exposes 
the catalytic activity site of CaMKII. CaMKII can also be autophosphorylated and 
partially activated in the absences of Ca
2+
/CaM 
58
. Wehrens et al. demonstrated that 
CaMKII mediated RyR2 phosphorylation at Ser-2815 increases the SR Ca
2+
 release by 
increasing the probability of opening of RyR2 
59
. CaMKII activity and subsequent 
phosphorylation of RyR2 are increased at faster heart rates 
60
 due to the “Ca2+ memory” 
properties of CaMKII, thereby during each contraction a fraction of the CaMKII 
monomers become activated and faster frequencies cause a stepwise increase in the 
number of activated monomers 
61
. This led to the proposal that CaMKII-dependent 
phosphorylation of RyR2 contributes to the force-frequency response, the observation 
that cardiac contractility increases as a function of heart rate 
60
. The levels of one of the 
isoforms of CaMKII, CaMKII, are elevated in heart failure samples, suggesting that 
CaMKII phosphorylation of Ser2815 on RyR2 (increasing the SR-Ca
2+
 leak), may 
contribute to cardiac pathogenesis 
62
. There are also contradictory evidences suggesting 
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that pathological consequences of CaMKII activation in heart failure are not a result of 
phosphorylation of RyR2 
63
.   
 
c. Calcineurin  
 
In response to elevated levels of Ca
2+
, calmodulin (CaM) binds to calcineurin (CaN), a 
serine/threonine phosphatase, leading to its activation. CaM binds to a regulatory domain 
within CaN leading to a conformational change that displaces the autoinhibitory domain 
from the active site, resulting in activation of phosphatase. This mechanism is the same as 
the activation of CaM-dependent protein kinases
64
. The highly conserved phosphatase 
CaN plays very important roles in numerous processes including T-cell activation, 
development and function of the central nervous system, and cardiac growth 
65
. 
Dysregulation of CaN might lead to various pathological conditions including vardiac 
hypertrophy.  
 
NFAT family of transcription factors is one of the principle targets of CaN. Followed by 
the dephosphorylation by CaN, NFATs translocate to the nucleus where they exert wide 
range of transcriptional effects. Figure 6 shows how Ca
2+
 entry influences CaN activation 
leading to NFAT dephosphorylation. It was speculated that GATA4 binding proteins 
might mediate certain aspects of the hypertrophic program and identified GATA4-
NFATc4 interaction 
66
. Overexpression of CaN in vivo resulted in drastic increases of 
cardiac hypertrophy, ventricular dilatation, cardiac fibrosis and pulmonary oedema, which 
led to premature death due to heart failure. This finding was reinforced by the discovery 
of increased CaN, NFAT and GATA4 activity in samples of failed human hearts 
67
. It was 
also evident that in contrast to the activation of other regulators of hypertrophy such as 
CaMKII and MAPK, CaN is relatively insensitive to transient increases in [Ca
2+
]i and 
that it is rather activated by sustained levels of Ca
2+
 
68
. Several Ca
2+
 channels including 
TRPC transient receptor potential canonical channels, L-type Ca
2+
 channels and T-type 
Ca
2+
 channels may also have a role in CaN activation.  
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Figure 6: The sarcolemmal microdomain of calcineurin. Calcineurin becomes activated 
by calcium that enters the cell through the TRPC, L-type or T-type calcium channels. 
These channels, in addition to other proteins influence calcineurin activation (green 
proteins have an activating role, while red proteins show inhibitory influence on 
calcineurin activity) that ultimately leads to NFAT dephosphorylation and its 
translocation to the nucleus. Adapted from Heineke J and Ritter O, 2012. 
 
Ca
2+
 entry via LTCC induces CaN activity and the physical interaction between CaN and 
Cav1.2 has been shown to enhance L-type Ca
2+
 currents
69-70
. CaN directly interacts with 
N- and C-terminal regions of the 1C unit. Through these interactions CaN is able to 
dephosphorylate the L-type Ca
2+
 channel and thereby modulate channel opening. Hence, 
activation of CaN enhances, while its inhibition reduces L-type channels currents, while 
its inhibition has the opposite effect 
70
. Also, a CaN-dependent increase in L-type Ca
2+
 
current was also reported in mouse hypertrophy models 
71
. Cardiac overexpression of the 
pore-forming 1C subunit of the L-type Ca2+ channel in transgenic mice leads to 29-44% 
increase in Ca
2+
 currents in transgenic CMs and also leads to cardiac hypertrophy, which 
is associated with enhanced cardiac interstitial fibrosis 
72
. Experiments have shown that 
the pharmacological inhibition of L-type Ca
2+
 channels leads to the reduction of cardiac 
hypertrophy in human patients 
73-75
.  
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While L-type Ca
2+
 channels play a key role in excitation-contraction coupling, T-type 
channels play only a minor role in the process and, instead, seem to be engaged primarily 
in Ca
2+
-triggered signal transduction 
76
.  A recent report has shown the localization of 
α1H and α1G channels within the caveole in neonatal and adult CMs, which implies an 
important role in the modulation of caveolae-based signaling 
77
. It has also been reported 
that mice with a genetic deletion of α1H show a dramatic reduction in the development of 
myocardial hypertrophy in response to pressure overload and angiotensin II stimulation. 
CaN also physically interacts with α1H, supporting the existence of both proteins within 
the same signaling domain 
78
. Contrastingly, α1G T-type channel appears to mediate anti-
hypertrophic functions through coupling activation of NO-synthase NOS3 
79
. These data 
show that CaN/NFAT signaling and cardiac hypertrophy at the sarcolemma are regulated 
by a specialized subset of L-type Ca
2+
 channels and a majority of T-type Ca
2+
 channels 
(most likely within caveolae) 
80
. 
Thus, L-type and T- type Ca
2+
 channels play an important role in Ca
2+
 signaling via Ca
2+
 
binding proteins. Any interference in Ca
2+
 signaling due to disfunction of these VGCCs 
will lead to distruption of Ca
2+
 homeostasis resulting in endoplasmic reticulum stress.   
 
4. Endoplasmic reticulum stress: 
 
4.1. Introduction 
 
The endoplasmic reticulum (ER) is a dynamic intracellular organelle with multiple 
functions for cellular homeostasis, development and stress responsiveness. The ER plays 
a critical role in many cellular processes including synthesis, folding, modification and 
transport of proteins, synthesis and distribution of phospholipids and steroids and storage 
of Ca
2+
 ions within its lumen. Disturbance in any of these functions results in ER stress 
and aggregation of misfolded proteins. ER stress has been observed many 
pathophysiological conditions like nutrient deprivation, viral infection, 
ischemia/reperfusion and cardiomyocyte hypertrophy 
81
. 
  
4.2. Endoplasmic reticulum and calcium homeostasis 
 
Ca
2+
 being a ubiquitous second messenger, participates in a wide variety of cellular 
processes, including protein synthesis, muscle contraction, gene expression, secretion, 
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cell cycle, metabolism, etc. 
82
. The ER is the principal organelle involved in Ca
2+
 
homeostasis and one of the important functions of ER, that is protein folding, is Ca
2+
-
dependent. The cytoplasmic Ca
2+ 
regulation depends on the activity of a series of 
transporters in the ER membrane. 
The
 SERCA pump imports Ca
2+
 from the cytoplasm into 
the ER lumen, whereas the RyR and inositol 1,4,5-triphosphate receptor are the Ca
2+
 
channels that release the Ca
2+
 ions back into the cytoplasm 
83-85
. 
Protein folding requires a highly oxidative, Ca
2+
-rich environment and an abundance of 
ER-resident molecular chaperones, including glucose- regulated protein 78 (GRP78 or 
BiP), GRP94, calnexin, calrectulin and protein disulphide isomerase (PDI). The nascent 
polypeptides translocate into the ER where they mature to form their most 
thermodynamically stable native structure, before being secreted into the extracellular 
space or transported to other organelles. The molecular chaperone GRP78 facilitates the 
protein folding mechanism. Perturbation of the Ca
2+
 homeostasis results in protein 
misfolding or disruption in the ability of the ER to correctly fold proteins. Normally cells 
ensure that proteins are correctly folded using a combination of molecular chaperones, 
foldases and lectins. However, when proper folding cannot be restored, incorrectly folded 
proteins are targeted to ER-associated degradation pathways (ERAD) pathways for 
processing 
86
. Any disruption in the Ca
2+
 homeostasis in the ER lumen will affect the 
protein folding activity of the ER, leading to ER stress. To monitor the protein folding 
process and to ensure that only native proteins are exported to their final destination, cells 
have evolved a sensitive quality control system called the unfolded protein response 
(UPR) system. This intricate mechanism is an important means of reestablishing cellular 
homeostasis and alleviating the inciting stress. The emerging evidences demonstrate that 
the UPR influences cellular metabolism through diverse mechanisms, including Ca
2+
 and 
lipid transfer, raising the prospect of involvement of these processes in the pathogenesis 
of disease, including cardiovascular disease, cancer, neurodegeneration and diabetes 
mellitus.  
In mammalian cells, UPR is a complex signaling program mediated by three ER 
transmembrane receptors, namely activating transcription factor (ATF6), inositol 
requiring kinase 1 (IRE1), and double stranded RNA-activated protein kinase-like 
endoplasmic reticulum kinase (PERK). In the physiological state, GRP78/Bip binds to 
and suppresses the activity of these three proximal, ER-resident transmembrane UPR 
transducers 
87
.  
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Figure 7: Illustrative diagram representing ER stress and UPR activation. Binding of Bip 
to misfolded proteins results in phosphorylation of UPR transducers PERK, IRE1 and 
activation of ATF6, leading to the induction of various UPR genes. B.L.Williams and W.I. 
Lipkin,2006. 
 
During ER stress, Bip binds to misfolded proteins and is thereby sequestered from PERK, 
IRE1 and ATF6 (Figure 7)
88
 . When released from GRP78/Bip, the kinase domain of the 
activated PERK phosphorylates Ser51 of the α subunit of the eukaryotic translation 
initiation factor1 (eif2α), thereby attenuating global translation initiation and protein 
synthesis 
89
. PERK-mediated phosphorylation of eif2α preferentially induces translation 
of activating transcription factor 4 (ATF4)
90
.  Followed by GRP78/Bip release, IRE1 
undergoes dimerization and trans-autophosphorylation, activating its endoribonuclease 
activity, IRE1 then mediates the excision of a 26- nucleotide intron from X-box binding 
protein 1 (XBP1), resulting in a translational frameshift and formation of a potent 
transcriptional activator 
91
. Bip-free ATF6 is transported to the golgi, where it is cleaved 
by site-1 and site-2 proteases, generating a 50 kDaKDa bZIP transcription factor 
(ATF6p50) that migrates to the nucleus 
92
. The downstream nuclear effectors of the UPR 
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regulate the expression of genes that enhance the protein folding and degrading capacity 
of the ER, regulate amino acid metabolism, mediate resistance to oxidative stress and 
induce apoptosis 
93
.  
 
4.3. ER Stress in the Myocardium  
 
There are several studies that correlate ER stress with myocardial damage. For example 
the hearts of transgenic mice that overexpress monocyte chemoattractant protein-1
94
. ER 
stress is activated in such hearts resulting in heart failure. This experiment suggests that, 
in this model, the preapoptotic phase of ER stress contributes to the loss of myocardium 
associated with failure. On further exploration of the role of ER stress in heart failure, it 
has been found that the transgenic overexpression of a mutant KDEL receptor, an ER 
protein that facilitates ER protein targeting, activates the ER stress response in mouse 
hearts and causes dilated cardiomyopathy. Also, overexpression of the ER stress response 
gene p53-upregulated modulator of apoptosis (PUMA) contributes to ER stress-mediated 
apoptosis in cultured CMs 
95
 and targeted deletion of PUMA in mouse hearts attenuates 
CMs death during ex vivo ischemia/reperfusion (I/R) 
96
.  There are also contradictory 
results that suggest that ER stress might protect heart and even foster hypertrophic growth 
of the myocardium. Studies also suggest that the prosurvival phase of ER stress might 
help accommodate the increased protein synthesis that takes place during overload-
induced hypertrophy 
97
.  
ER stress might also play an important role in developing myocardium. GRP78 
expression is upregulated in the neonatal mouse heart compared to the adult mouse 
heart
98
. Moreover, GRP78 is required for normal cardiac development
99
.  
It has also been shown that targeted disruption of XBP1 gene in mice proved to be 
embryonically lethal due to cardiac developmental defects
100
. This indicates that ER 
stress response is required for proper cardiac development. Since ischemia activates ER 
stress in the brain, several studies were done to assess the ER stress response in 
myocardium by ischemia or I/R. Studies revealed that numerous ER stress response genes 
were activated within 24 hours of in vivo myocardial infarction in mouse hearts 
101
. 
Studies also showed that the expression of several ER stress markers increased in mouse 
hearts subjected to I/R. All these studies pointed towards the cardioprotective effect of ER 
stress response.  
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A further study in support of protective roles for ER stress showed that overexpression of 
activated ATF6 in transgenic mouse hearts decreased ischemic damage and increased 
ventricular pump function in an ex vivo I/R model 
102
  However, it’s still not clear if the 
ER stress is protective or damaging. Perhaps mild and brief episodes of ischemia favour 
activation of prosurvival aspects of ER stress, whereas severe or long episodes of 
ischemia eventually activate proapoptotic aspects. Other factors including the presence of 
additional ER stress, or existent cardiac pathologies may influence the time to transition 
between the prosurvival and proapoptotic aspects of ischemia-activated ER stress 
103
. 
Sustained UPR resulting from ER stress could also lead to the removal of misfolded poly-
ubiquitinated protein aggregates by a self-eating process called autophagy which could be 
a prosurvival mechanism adapted by the cell. Basal autophagy is seen in the developing 
heart, which makes it important for protein quality control and the normal functioning of 
heart. Thus it becomes necessary to study about autophagy and the link between ER stress 
and autophagy.  
 
5. Autophagy 
 
5.1. Introduction  
 
Autophagy, one of the major catabolic mechanisms of a cell, is an evolutionarily 
conserved mechanism of recycling long lived proteins and clearance of defective 
organelles 
104
. Basal autophagy is known to be critical for the fundamental housekeeping 
function of cell survival and homeostasis 
105
.  In addition, autophagy also plays 
significant roles in metabolism by replenishing energy substrates and governing 
mitochondrial number and quality control 
106
.  It is a near-ubiquitous process of delivery 
of cytoplasmic materials, including proteins and organelles, to lysosomes for 
degradation
107
. Based on the differences in function and mechanism, autophagy has been 
divided into three types namely, microautophagy, macroautophagy and chaperone 
mediated autophagy. Macroautophagy (referred commonly as autophagy) is the most 
common form of autophagy.  
Macroautophagy is a bulk degradation process for cytosolic proteins and organelles 
which involves 3 major steps: formation of ultrastructurally distinct double membranous 
vesicles called as autophagosomes, fusion of autophagosomes with lysosomes and 
degradation by the lysosomal acid hydrolases and proteases 
108-109
. In macroautophagy, 
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the impaired cytoplasmic components are engulfed in an autophagosome, which then 
fuses with the lysosome to deliver its contents for degradation in the mature 
autolysosome. 
The core autophagic machinery consists of evolutionarily conserved signaling molecules 
encoded by autophagy related genes (ATG) that governs the whole macroautophagic 
process. They are 1) the Atg1 kinase complex (composed of at least Atg1-Atg13-Atg17-
Atg31-Atg29) and the mammalian ULK1/2 complex including ULK1/2-ATG13-
RB1CC1-CC12 orf44/ATG10.  2) The phosphatidylinositol 3-kinase composed of 
Vps34-Vps15-Vps30/Atg6-Atg14 and the mammalian counterpart including 
PIK3C3/VPS34-PIK3R4/VPS15-BECN1-ATG14. 3) The ubiquitin-like protein 
conjugation cascades involving Atg3,Atg4, Atg5, Atg7, Atg8 (and the mammalian LC3 
and GABARAP subfamilies), Atg10, Atg12 and Atg16 and the corresponding 
mammalian homologs, which are required for phagophore expansion, autophagosome 
maturation and cargo recruitment. 4) A recycling protein complex composed of Atg12, 
Atg9, Atg18, and Atg21 and the mammalian homologs including WIPI1/2, which 
participates in the transfer and recycling of components between the phagophore and the 
phagopore assembly site and membrane donor sites 
110
. 
  
Autophagy plays a variety of functions. (1) Autophagy induced in response to starvation, 
promotes cell survival by allowing a cell to break down non-essential or excessive 
cellular components, thus releasing substrates that facilitate the generation of ATP and 
the recycling of molecules such as essential amino acids that the cell itself cannot 
manufacture de novo. (2) Autophagy that serves as a primary route for the removal of 
excess or damaged organelle, is capable of engulfing and degrading complex aggregates 
of misfolded or damaged proteins that are too large to be handled by the proteasome 
111
. 
(3) It is involved in both innate and adaptive immunity by degrading invading pathogens 
and delivering self-antigens for MHC-class-II loading. (4) Autophagy may also contribute 
to cell death. Autophagy mediated cell-death has been termed as type-II programmed cell 
death in contrast to type-I apoptotic programmed cell death. In certain diseases, 
particularly in neurodegenerative diseases there is a clear correlation between cell death 
and abundance in autophagic vesicles. However, cell death could occur not because of 
abundance in autophagic activity; rather the inefficiency in processing the autophagic 
vesicles or deficient autophagic activity could affect the cell viability 
112
. In the regulation 
of autophagic flux, the autophagosome processing involves three discrete steps, namely 
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nucleation, elongation and fusion. In addition, there are also three control check points in 
regulating autophagic flux namely, induction, substrate targetting and degradation.  
 
a. Nucleation 
 
The nucleation of an autophagic isolation membrane is initiated by the activation of a 
class III phosphoinositide 3-kinase (PI3K), called Vps34, by its binding partner Beclin1. 
Class III PI3 kinases phosphorylates the three position –OH group of the inositol ring of 
phosphatidylinositol (PI), a negatively charged membrane phopspholipid to produce 
PI(3)P. PI(3)P then recruits additional proteins required for the formation of isolation 
membrane 
113
. This process of formation of the isolation membrane is regulated by a 
system of evolutionarily conserved proteins (Atg proteins). Beclin1 (Atg6), a part of a 
PI3-K plays an important role during the initial steps of autophagosome formation by 
mediating the localization of other Atg proteins to the isolation membrane.  
 
b. Elongation 
 
The synthesis of autophagosomes requires the Atg5-Atg12 and LC3 (Atg8) - 
phosphotidylethanolamine (PE) conjugation systems. The covalent conjugation between 
Atg12-Atg5 is similar to that of ubiquitination where Atg12 is first activated by Atg7, and 
then transferred to Atg10. Atg12 is then covalently conjugated to Atg5 at a lysine residue 
and Atg10 is released 
114
. The Atg12-Atg5 complex interacts non-covalently with Atg16, 
and this complex recruits covalently linked phospholipid PE and LC3 (LC3-PE) to initiate 
the elongation process 
115
. Lipidation of LC3 converts it from the LC3-I form to the LC3-
II form and allow insertion of the protein into the growing autophagic membrane. The 
free cytoplasmic protein end of LC3-II identifies the membrane as an autophagosome and 
allows targeting selective substrates. LC3-II is therefore a potential avenue for targeting 
active autophagosomes prior to their fusion with lysosomes 
116-117
. The basic method to 
monitor the regulation of autophagic flux is by monitoring the conversion of LC3-I to 
LC3-II by western blot and the use of green fluorescent protein fused to LC3 (GFP-LC3) 
to visualize the vesicle formation.  
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c. Fusion 
 
The fusion of mature autophagosomes to lysosomes can be either direct or mediated by 
endosome fusion. Most of the components required for this process play a major role in 
vesicular trafficking in general and are not specific for autophagy.  
 
d. Induction 
 
Kinase mammalian target of rapamycin (mTOR) acts as a central control point for the 
induction of autophagy.  mTOR lies downstream of insulin signaling and class I PI3K 
118
. 
Many of the mechanisms that promote or inhibit autopahgy converge in some way on 
mTOR and the induction complex 
119
. In contrast to class III PI3K, class I PI3K generates 
PI(3,4)P2 and PI(3,4,5)P3 in addition to PI(3)P from PI.  Binding of insulin or other 
growth factors to receptors in the plasma membrane activate Class I PI3K. PI(3,4)P2 and 
PI(3,4,5)P3 formed at the plasma membrane, then recruit phosphoinositide-dependent 
kinase-1 and protein kinase B (AkT) to the membrane via their pleckstrin homology 
domains resulting in sequential activation 
120
. The cascade of events activated by Class I 
PI3K at the plasma membrane leads to activation of mTOR and inhibition of autophagy. 
There are two distinct mTOR complexes, which target different downstream components. 
The mTORC1 complex is sensitive to rapamycin. It promotes cell growth by blocking 
autophagy through ULK1 phosphorylation and by increasing protein translation through 
phophorylation of ribosomal protein S6 kinase, eEf2  kinase and translational repressor  
4E-BP1. Thus activation of mTOR could promote cellular catabolism, whereas, inhibition 
of mTOR could promote anabolism. 
 
e. Substrate targeting 
 
The autophagy that is induced by starvation is non-selective and it degrades a diversity of 
cellular components at one time to maintain the cellular homeostasis. However, 
autophagy can also selectively remove damaged or excess cellular components. Though a 
diversity of organelles and cellular components could be eliminated through selective 
degradation, cells recruit ubiquitination process to maintain specificity 
121
. Adaptor 
proteins like p62/SQSTM1 contain both a ubiquitin binding domain and a LC3 interacting 
region. So the ubiquitination of misfolded protein aggregates or a protein in the outer 
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membrane of an organelle provides essential tagetting signals to attract such adaptor 
proteins. P62/SQSTM1 on the other hand recruits ubiquitinated targets to the nascent 
phagophore by binding to the cytoplasmic tail of the LC3 II in the membrane of the 
autophagosome. Selective specificity is based on the transmission of appropriate signals 
from the target component to recruit the appropriate ubiquitin ligase and the specific 
adaptor protein.  
 
f. Degradation 
 
The substrates recruited by the adaptor proteins are delivered to the autolysosome via 
LC3 II binding for degradation. The degraded components are released in to the 
cytoplasm by the permeases. Thus degradation process acts as a final step in controlling 
the autophagic flux.  
The autophagic activivity has been measured by the presence of double membrane bound 
autophagosomes on electron micrographies. Importantly, the abundance of 
autophagosomes not only reflects the increase in autophagosome formation but also a 
decrease in the lysosomal processing of autophagosomes. Thus the ultrastructural changes 
resulting from an increase in autophagic activity can be indistinguishable from abundance 
in autophagosome caused by blocking the autophagic activity 
116
. 
There are few techniques that are used for assessing changes in autophagic flux in 
cultured cells. 1) Addition of lysosomal protease inhibitors like Bafilomycin A1 to the 
media prevents the fusion of autophagosome with the lysosome, thereby blocking 
autophagy. The increase in LC3-II simply indicates the increase in autophagosome 
formation. But in the presence of a lysosomal protease inhibitor, LC3 II accumulates 
further, indicating the enhancement of autophagic flux. 2) Changes in the levels of 
adaptor proteins like p62/SQSTM1 is also useful in assessing the changes in autophagic 
activity. Inhibition of autophagy results in an accumulation of p62/SQSTM1 whereas 
increase in autophagic activity results in decrease of p62/SQSTM1. 3) New techniques 
involving GFPLC3 are also developed for studying the autophagic flux
122
. 
 
5.2.  Autophagy and Calcium 
 
The first report on the Ca
2+
-dependent regulation of autophagy suggested that both the 
chelation of either intracellular or extracellular Ca
2+
 ions and the elevation of cytosolic 
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Ca
2+
 levels suppressed autophagy. After this, some reports suggested that cytosolic Ca
2+
 
stimulates autophagy while others report that cytosolic Ca
2+
 and Ca
2+
-handling proteins 
inhibit autophagy (see below). Indeed, Ca
2+
 signaling may have opposite effects in 
normal cells versus stressed cells, and differently regulate basal autophagy and 
augmented autophagic activity in response to stress.  
 
5.2.1. Cytosolic calcium as an inducer of autophagy 
 
Autophagy that is stimulated by vitamin D, ionomycin and thapsigargin has been known 
to be induced due to ER Ca
2+
 mobilization 
123
. It has also been proved that autophagy 
occurred by the Ca
2+
-dependent activation of AMP activated protein kinase (AMPK), 
which required upstream activation of Ca
2+
 / CaM kinase kinase . AMPK is activated 
during starvation to inhibit the activity of mTOR. In addition, the calcium phosphate 
transfection method has been shown to induce a Beclin1 dependent autophagy in HEK-
293 cells, proving the potential of Ca
2+
 as an autophagy inducer 
124-125
. 
 
5.2.2. Cytosolic calcium as an autophagy inhibitor 
 
Ionositol 1,4,5- trisphosphate (IP3) receptor which is located at the ER is an ubiquitously 
expressed intracellular Ca
2+
 release channel. IP3Rs may mediate Ca
2+
 release from the ER 
to the cytosol, in response to elevations in the cytosolic IP3 levels produced in the cells 
after stimulation by hormones, growth factors or antibodies 
126
. It has been shown that 
while moderate elevations of cytosolic Ca
2+
 activate IP3Rs, higher Ca
2+
 levels exert the 
opposite effect 
127-128
. Many cytosolic proteins including protein kinases and 
phosphatases, directly bind and regulate IP3Rs, and in turn control ER Ca
2+
 flux 
properties. IP3-induced Ca
2+
 release towards the mitochondria promotes ATP production, 
inhibition of AMPK and resulting in stimulation of mTOR activity. mTOR can stimulate 
the IP3Rs by direct phosphorylation
129-130
. 
 
Thus, spontaneous Ca
2+ 
signals may suppress basal autophagy in healthy cells through 
mitochondrial pathways, acting as a quality control system to maintain cell homeostasis; 
stress conditions may promote Ca
2+
 signaling and may elevate Ca
2+
 in the cytosol 
resulting in autophagy stimulation through cytoplasmic effector molecules. On the other 
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hand, IP33Rs can also inhibit the dissociation of Beclin1 from BCl-2, independently of its 
Ca
2+
 release activity 
131
. It has been well established that a fraction of IP3Rs present in ER 
domains are in close association with mitochondria
132
. These domains allow efficient 
transfer of Ca
2+ 
ions from the ER to the mitochondria
133
. The spontaneous Ca
2+
 flux to the 
mitochondria indicates that the cells are healthy and they do not require activating 
autophagy. Reducing these Ca
2+
 signals activate autophagy. Further reduction of these 
Ca
2+
 signals lead to the activation of ER-stress-induced apoptosis
134
. Also, blockade of L-
type Ca
2+
 channels will result in an abnormal low Ca
2+
 transfer to the mitochondria 
135
. 
Although the exact mechanisms behind the Ca
2+
 signaling switch from anti-autophagic to 
pro-autophagic are yet to be clarified, it’s clear that IP3Rs combined with proteins like 
BCl-2 and Beclin1 play a central role in both the processes and regulate the Ca
2+
- 
signaling in basal and stress conditions 
136
.  
 
5.3. Autophagy in heart 
 
Basal cardiomyocyte autophagy is a very important process for cardiomyocyte function 
and survival. It has been shown that vitiating autophagic pathways in adult heart by 
conditional inactivation of either Atg5 or Atg7 genes resulted in rapid-onset of cardiac 
hypertrophy, left ventricular dilation and diminished cardiac output 
137
.  It has also been 
observed that effect of aging (and a concomitant decrease in basal autophagy) leads to the 
accumulation of defective proteins and organelles leading to functional defects 
138,139
. 
These observations show that the housekeeping cardiomyocyte autophagy is essential for 
protein quality control. Figure 8 illustrates the major molecules and molecular pathways 
that are known to regulate autophagy in ventricular CMs. 
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Figure 8:  Simplified scheme of the major cellular pathways governing autophagic flux in 
ventricular CMs. Adapted from Lavandero S et al. 2013. 
 
5.3.1. Afterload induced autophagy 
 
Pathological stress due to nutritional scarcity or hypoxia results in a rapid increase in 
autophagic flux and help to replenish scarce nutrients 
105,140
. On the other hand, 
suppression of autophagy during starvation reduces intracellular ATP levels and 
diminishes cardiac output 
141
. In spite of this, pathological conditions resulting from 
elevated afterload, chronic ischemia and ischemia/reperfusion are associated with 
induction of high level autophagy. There are arguments that say cardiomyocyte 
autophagy could be adaptative or maladaptative depending on the context and amplitude 
of its induction during pathological conditions 
142
. Activation of autophagy has proved to 
be protective during ischemic conditions whereas it could be detrimental in the load-
stressed heart and during post-ischemic reperfusion 
143
.  
Beclin1, a molecular element critical to initiate autophagy 
144
, upon overexpression 
specific for CMs, accelerated the load stress-induced autophagy, resulting in cardiac 
failure. Conversely, diminishing the autophagic response by 50% in Beclin1 
haplosufficient mice attenuated pathological remodeling induced by after load stress 
145
. 
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Excessive autophagy can lead to the removal of key molecules and organelles, triggering 
autophagic cell death. On the other hand, in case of proteotoxic cardiomyopathy, an 
increased autophagic flux helps in the removal of toxic, misfolded, oxidized protein
146
. 
Thus the underlying cardiomyopathic stimuli lead to the functional differences in the 
actions of autophagy.  
 
5.3.2. Autophagy in myocardial ischemia and ischemia/reperfusion 
 
Hypoxia is capable of rapidly inducing a cell survival response engaging autophagy by 
activating the hypoxia inducible factor (HIF-1). This cell survival response is mediated by 
the BH3-only protein Bcl-2/E1B 19 kDa-interacting protein 3 (BNIP3/BNIP3L (NIX)) 
that is induced by HIF-1. Mitochondria-associated BNIP proteins also mediate 
mitophagy, a metabolic adaptation that controls ROS production and DNA damage. In 
addition, severe hypoxic conditions can induce HIF-independent autophagic response 
which is an outcome of extreme nutritional stress response involving AMPK-mTOR and 
UPR pathways
147-148
.  
 
               
Figure 9: Myocardial ischemia and reperfusion elicit conditions that strongly induce 
autophagy including energy starvation, ER stress, protein aggregation etc. Although 
autophagy induction by ischemia is protective, enhancement of autophagy during 
reperfusion could induce cell death in the heart. (Adapted from Matsui et al, 2008) 
Introduction 
47 
 
 
Although there have been several reports on the induction of autophagy upon ischemic 
insult in various cell systems
149
, there is a question of debate on the effects of autophagy 
in ischemia/reperfusion injury. During mild ischemia, cardioprotective autophagy is 
activated by AMP-activated protein kinase (AMPK) mediated inhibition of mTOR and 
this autophagy is adaptative and exerts a pro-survival effect. However, when oxygen and 
nutrients are restored during reperfusion, cardiomyocyte autophagy is upregulated 
dramatically involving the over-expression of Beclin1, with detrimental effects for CMs 
143,150
. 
             
5.3.3. Autophagy in Cardiac hypertrophy 
 
During myocardial infarction, the heart undergoes a compensatory hypertrophic growth 
response. This hypertrophic response might trigger myocyte death, ventricular dilation, 
diminished contractile performance, and a clinical syndrome of heart failure 
151
.  
There are several humoral factors that also act as hypertrophy stimulants in CMs. First 
group of hypertrophic stimulants are growth factors such as fibroblast growth factor, 
insulin-like growth factor, and others 
152-153
. These growth factors through several second 
messenger cascades activate physiological or adaptive hypertrophic growth. A second 
group of humoral stimulus arises from the activation of heptahelical G-protein coupled 
receptors like beta 1-adrenergic receptors, AT1 receptor for angiotensin II (Ang II) and 
ET receptor for endothelin-1
154
. Chronic elevation of plasma Ang II has been identified as 
a major cause in the pathogenesis of hypertrophy and is also known to play a role in 
cardiac remodeling. Activation of α-adrenergic receptors and in turn activation of PKC 
also is considered as a powerful stimulus for cardiac hypertrophy
155
. The third group of 
hypertrophy stimulus is activation of mineralocorticoid receptors by aldosterone. 
Aldosterone binds to mineralocorticoid receptor and enters the nucleus to regulate gene 
expression. Aldosterone signaling is associated with GATA4 transcription, which is 
induced during hypertrophic stimuli. Aldosterone also increases AT1 receptor density 
thereby leading to aldosterone-induced cardiac hypertrophy and myocardial fibrosis 
ultimately leading to heart failure
156-158
. 
Autophagy has been now known to play a critical role in heart failure. Experiments have 
shown that in isolated neonatal myocytes, inhibition of autophagy by knockdown of Atg7 
induced hypertrophy and also that the conditional deletion of Atg5 increased the size of 
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myocytes 
159
. It has also been shown that rapamycin, a potent inducer of autophagy, 
prevents cardiac hypertrophy induced by thyroid hormone treatment 
160
.  Thus autophagy 
might antagonize cardiac hypertrophy by increasing protein degradation and reducing 
cardiac mass. Disrupting the gene coding for Beclin1 decreases cardiomyocyte autophagy 
and diminishes pathological remodeling induced by severe pressure overload. On the 
contrary, Beclin1 over expression increases autophagic activity and accelerates 
hypertrophy 
161
.  
 
5.4. Cardiac autophagy as a therapeutic target 
 
The incidence of heart failure remains high in spite of significant advances in both 
pharmacologic and device based cardiovascular therapeutics 
1
. Our level of understanding 
of cardiac plasticity and remodeling is insufficient for the utility of these advancements in 
therapeutics 
162
. However, recent findings on cardiomyocyte autophagy could prove it to 
be a novel therapeutic target in treating heart failure. In the process of cell growth, both 
anabolic and catabolic pathways are activated. In the initial phase, the anabolic process is 
higher and cell growth emanates. When this cell growth reaches a steady state the 
autophagic flux increases. It has been shown that cardiomyocyte autophagy triggered by 
elevation in afterload has both adaptative and maladaptative features. Activation of 
autophagy during pressure stress maybe beneficial, but over-activation of autophagy has 
detrimental consequences 
163
. The prevalence of autophagy in various cardiac disorders 
suggests the existence of a common cellular pathway that could be targeted for the 
therapeutic gain 
164
. 
 
6. ER stress-induced autophagy 
 
ER stress is caused by accumulation of unfolded, misfolded or damaged proteins that 
exceeds the capacity of protein folding chaperones in the ER. The unfolded protein 
response sets up to eliminate this stress and can also lead to the induction of autophagy. 
In mammalian cells, the UPR signaling is more complicated than in yeast 
165
. The three 
ER stress transducers, namely PERK, ATF6 and IRE1, sense the level of unfolded protein 
in the ER and activate transcription of numerous genes. In addition to UPR, ER stress 
also results in release of Ca
2+
 from the ER and hence increases the cytosolic Ca
2+
 in the 
cell 
5
. In resting conditions the ER-resident chaperone GRP78 binds to all three UPR 
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transducers and, during stress conditions, GRP78 binds instead to missfolded proteins 
166
. 
Once released, PERK, IRE1 and ATF6 mediate the UPR survival response to restore the 
ER homeostasis 
167
. To further reduce the ER load, the UPR encompasses the 
translocation of the ER proteins to the cytoplasm, where they are degraded through 
ERAD 
168
. In situations of prolonged stress, upregulation of CHOP /GADD153 leads to 
the activation of apoptosis. But in some situations, autophagy can intervene and remove 
the accumulated polyubiquitinated aggregates thus preventing cell death 
169
. 
 
 
 
 
Figure 10: Integration of ER stress and macroautophagy with the regulatory network 
controlling the maintenance of cellular homeostasis. During ER stress GRP78 induces 
both autophagic vesicle formation and UPR through different mechanism. Adapted from 
Benbrook et al, 2012. 
 
It has been demonstrated that ER stress induces autophagy directly through the 
upregulation of GRP78 and through mechanisms downstream of the GRP78 release of the 
three UPR transducers (Figure 9) 
170
. The knockdown of GRP78 in normal and cancer 
cells has been shown to prevent the formation of autophagosomes in response to 
starvation. The dilated and distrupted ER and the deficient autophagosome formation 
induced by knockdown of GRP78 were known to be simultaneously alleviated by 
knockdown of XBP1- transcription factor 
171
, suggesting that an intact ER is maintained 
by and/or required for autophagy. The link between GRP78 and autophagy induction 
occurs downstream of nucleation, as the knockdown of GRP78 did not prove to have any 
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effect on the association between Beclin1 and Vps34 
171
, a class III phosphatidylinositol 
3-kinase (PI3K) critical for the initiation of autophagosome biogenisis.  
The PERK-eIF2α signaling pathway is also known to mediate ER stress-induced 
autophagy in mammalian cells 
169
. ER stress induced by polyglutamine repeats (PolyQ) 
upregulate Atg12 expression and induces autophagy as interpreted from the conversion of 
LC3 I to LC3-II and the increase in the LC3-positive vesicles in the mouse embryonic 
carcinoma cells and murine embryonic fibroblasts (MEFs) 
172
. In addition, eIF2α 
mediates autophagy in systems that are not associated with ER stress as well. It has also 
been shown that PERK-dependent phosphorylation of eIF2α is essential for autophagy in 
MEFs infected with herpes simplex virus, and also that eIF2α phosphorylation is required 
for starvation induced autophagy 
173
. Other studies have established the link between the 
PERK arm of UPR and the upregulation of autophagy through the ATF4-driven 
transcriptional upregulation of the ATG genes 
174
. 
The UPR transducer IRE1α has been known to upregulate autophagy via IRE1α 
activation of c-Jun N terminal kinase (JNK). Studies have shown that pharmacological 
proteosomal inhibition induced ER stress and autophagy in colon cancer cells, but neither 
upon siRNA-mediated reduction of IRE1α nor in the presence of pharmacological 
inhibitors of JNK activity 
175
. In this study, the JNK inhibitor did not have any effect on 
XBP1 activation and was equally effective in XBP1-positive and –negative cells, 
indicating that the UPR mediated upregulation of autophagy occurs through the JNK but 
not the IRE1α arm of UPR. Thus, like GRP78, the function of XBP1 maybe required to 
maintain the ER in the functional state and to support autophagic vesicle formation. Both 
the knockdown of IRE1α, PERK or ATF6 and the use of a JNK inhibitor showed that ER 
stress-induced autophagy is dependent on IRE1α activation of JNK, but independent on 
PERK and ATF6 
169
. On the other hand, studies on breast cancer cells have shown that all 
the three UPR transducers appear to be involved in the induction of autophagy 
176
.  
From all these previous studies, it can be concluded that ER stress can induce UPR 
mediated transcriptional regulation of pro-autophagic genes, leading to the upregulation 
of autophagy. Also, it becomes clear that Ca
2+
 has its role to play in all these processes. 
The core idea of this thesis is to study the role of voltage gated Ca
2+
 channels in the 
regulation of Ca
2+
 homeostasis and macroautophagy in CMs. This can be achieved by 
pharmacologic or gene manipulation of the VGCCs, which will be discussed in the 
further chapters.  
 
  
 
 
 
 
 
 
Objectives
  
 
Objectives 
53 
 
Objectives 
 
The global objective of this study was to elucidate the involvement of voltage-gated Ca
2+
 
channels (VGCCs) in the regulation of Ca
2+
 homeostasis in neonatal ventricular CMs 
cultured in vitro, and study the mechanisms underlying the presumed cytoprotective 
effects due to their blockade.  
 
The experimental goals to achieve this objective were: 
 
1. To study the effects of the pharmacological blockade T-type and L-type VGCCs 
in cell viability. 
2. To study the induction of ER stress by VGCCs blockade, given the Ca2+-
dependence of ER homeostasis and its impact on cell viability. This goal was 
pursued through the study of the UPR and macroautophagy pathways, as likely 
outcomes of ER stress. 
3. To study the effects of gene silencing of VGCCs on cell homeostasis (a term 
encompassing UPR and autophagy), in order to identify the Ca
2+
 channel isoforms 
mediating the effects of the pharmacological blockers.  
4. To analyze the putative induction of UPR and macroautophagy upon hypoxia and 
hypoxia-reoxygenation, as in vitro experimental paradigms of chronic ischemia 
and ischemia-reperfusion, respectively. 
5. To analyze the putative induction of UPR and macroautophagy upon different 
hypertrophic stimuli. 
6. To analyze the expression profile of VGCCs in CMs subject to hypoxia, hypoxia-
reoxygenation or hypertrophic stimuli. 
7. To study the effects of VGCCs blockade on the viability of CMs subject to 
hypoxia, hypoxia-reoxygenation or hypertrophic stimuli and to study the 
mechanisms for a presumed cardioprotection of VGCC pharmacological blockers 
against detrimental effects of hypoxia, hypoxia-reoxygenation and hypertrophic 
stimuli  
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Table 2: 
 
1. Chemicals, reagents and cell culture materials 
 
Company 
 
Product 
Applied Biosystems(New Jersey, 
USA) 
TaqMan Universal PCR  Mastermix 
First strand c DNA synthesis kit for RT-PCR 
BD Biosciences 
(Bedford, MA, USA) 
Plates (100X20) 
Serological pipettes 
Thermo Scientific EZ ECL Chemiluminescence Detection kit for HRP 
Biorad Laboratories(CA,USA) 30% Acrylamide/Bis solution 29:1 
Falcon(BD Labware , USA) Serological pipet (different volume) 
Plates  100X 20 mm 
6 well plates for cell culture 
96 well plates for cell culture 
24 well plates for cell culture 
Fisher Scientific (Madrid ,Spain) Centrifuge tubes (different volume) 
Methanol 
GIBCO-Invitrogen(Carlsbad ,USA) Dulbecco’s modified Eagles medium (DMEM) 
254 medium supplemented with human melanocyte 
growth supplement (HMGS-2) 
Fetal bovine serum (FBS) 
Fungizone amphotericin B 
OptiMEM 
FURA-2/AM 
L-Glutamine 
LipofectamineRNAiMAX reagent 
Lipofectamine 2000 
Lysotracker red 
HEPES 
Horse serum (HS) 
Medium 199 (M199) 
Pencilin/ Streptomyicin 
Trypsin EDTA 
SYBR safe DNA gel stain 
Low molecular weight protein bench mark 
Merck (Barcelona, Spain) β Mercaptoethanol 
Millipore (Bedford, MA) Polyvinylidine fluoride (PVDF) membrane 
Roche (Germany) 2-(2-Methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-
(2,4-disulfophenyl)- 2H-tetrazolium (WST-1)  
Sigma Aldrich (Barcelona ,Spain) Ammonium persulfate (APS) 
Caffeine 
D-glucose 
Disodium Hydrogen Phosphate 
Calcium chloride 
Sodium hydroxide 
Manganese chloride 
Magnesium chloride 
Potassium chloride 
Dimethyl sulfoxide (DMSO) 
Dodecyl sodium sulfate (SDS) 
Gelatin from porcine skin 
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Glycerol 
Glycine 
Hoechst (Bisbenzimide H) 33258 
N,N,N',N'-tetramethyl-ethane-1,2-diamine (TEMED) 
Sodium chloride ( NaCl) 
Thapsigargin 
Tris base 
Triton X-100 
TRIzol reagent 
Tween-20 
Nimodipine 
Nifedipine 
 (S)-())-Bay K 8644 
Kurtoxin  
Mibefradil  
Poly-D-Lysine hydrobromide 
Monodansyl cadavarine (MDC) 
Aldosterone 
Angiotensin 
Phenylephrine 
Isoprenaline 
Chloroquine 
Panreac (Barcelona, Spain) Ethanol 
Hydrochloric acid (HCl) 
Isopropanol 
Sakura Finetechnical (Tokyo, Japan) Tissue Tek OCT 
Cascade Biologicals Inc.(Portland 
,OR,USA) 
Neonatal human epidermal melanocytes(HEMn-Lp) 
Gene Craft ( Germany) Taq DNA polymerase 
GE healthcare  50 base pair DNA ladder 
Thermo Scientific  EZ ECL Chemiluminescence Detection kit for HRP 
SuperSignal® West Dura Extended Duration 
Substrate 
Worthington, Lakewood, NJ, USA Type II collagenase 
 
 
Table 3: 
 
2. Antibodies 
 
Primary 
Antibody 
Molecular 
weight 
Dilution Company Secondary 
Antibody 
Atg5 Complex-56; 
33 
1: 2000 Sigma Aldrich Anti-mouse 
Beclin1 55 1: 10,000 Novus 
Biologicals 
Anti-rabbit 
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P62/sqstm1 47 1: 4000 Novus 
Biologicals 
Anti-rabbit 
LC3 19;17 1: 3000 Novus 
Biologicals 
Anti-rabbit 
GRP78 78 1: 3000 Santa Cruz Anti-goat 
Gadd 153 31 1: 1000 Santa Cruz Anti-mouse 
Ubiquitin 115 1: 500 Santa Cruz Anti-mouse 
α-actin 45 1: 5000 Sigma Anti-mouse 
β-actin 45 1: 5000 Sigma Anti-mouse 
 
 
 
Table 4: 
3. Sequence of short interfering RNA: 
 
Product name  Sequence Company 
siRNA Cav 3.1 5’-CGAUUCCUGUCCAAUGCUAtt-3’ 
3’-UAGCAUUGGACAGGAAUCGta-5’ 
Applied Biosystems 
siRNA Cav 3.2 5’-GCAUUGUAGACAGCAAGUAtt-3’ 
3’-UACUUGCUGUCUACAAUGCga-5’ 
Applied Biosystems 
siRNA Cav 3.3 5’-GCCUGUCACUCACAUCUCUtt-3’ 
3’-AGAGAUGUGAGUGACAGGCtg-5’ 
Applied Biosystems 
siRNA Cav 1.2 5’- CUCUAUACCUGUUCGGAUAtt-3’ 
3’- UAUCCGAACAGGUAUAGAGAGct-5’ 
Applied Biosystems 
siRNA Cav 1.3 5’-GGAAGUUCAAUUUCGAUGAtt-3’ 
3’-UCAUCGAAAUUGAACUUCCct-5’ 
Applied Biosystems 
 
 
 
 
 
 
Table 5: 
4. Oligonucleotides used to amplify transcripts of pore-forming Ca2+ channel 
subunits 
 
     Acc. no.                                                                                                                  Sequence Length
(bp) 
Temp. 
 
Cav1.2  NM_012517  5’-CTCGAAGTTGGGAGAACAGC-3’ 
3’-GACGAAACCCACGAAGATGT-5’ 
233 58°C 
 
Cav1.3  NM_000720 5’-TCCAGCAGGAAATTCGGTGTGTCA-3’  189 55°C 
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3’-TCGGTCGTGCTTGTAGGAGTAATG-5’  
Cav3.1  NM_031601 
 
5’-CATCCTGGTCTCCATGGTCT-3’ 
3’-GCAAATGACCACAATGTTGC-5’ 
178 55°C 
Cav3.2  NM_153814 
 
5’-ATCCTGGTCACTCTGCTGCT-3’ 
3’-ACCCTCCTCCGTCTCGTAGT-5’ 
201 55°C 
GAPDH NM_017008                5’-TCCCTCAAGATTGTCAGCAA-3’ 
3’-AATGTATCCGTTGTGGATCTCT-5’ 
308  55°C 
XBP1  5’-AAACAGAGTAGCAGCGCAGACTGC-3’ 
3’-GGATCTCTAAAACTAGAGGCTTGGTG-5’ 
290 63ºC 
Acc. no.: Accession number of the amplified gene; Length: length in base-pairs of the 
PCR product; Temp.: annealing temperature used in the PCR 
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1.  Cell culture 
The neonatal rat ventricular CMs were obtained as described by Pellieux et al
177
. The 
neonatal rat ventricles from 2 days old Sprague Dawley rats were separated from the atria 
by dissection and digested thrice at 37ºC by using 0.45 mg/ml type-2 collagenase 
(Worthington, Lakewood, NJ, USA) and ADS buffer containing 116 mM NaCl, 1mM 
NaH2PO4, 5.4 mM KCl, 0.8 mM MgSO4.7H2O, 5.5 mM glucose and 20MM Hepes at pH 
7.4. Dissociated cells were washed by low-centrifugation in medium consisting of 3:1 
mixture of DMEM 1g/L glucose and M199 (GIBCO) supplemented with 10% horse 
serum, 5% foetal calf serum, 2mM/L Glutamine, 10 mg/mL Streptomycin and 100 units 
of Penicillin. Cardiomyocytes were separated from non-myocytes by 2 rounds of 
differential plating for 45 mins each. Cells were plated at a density of 10
3
 cells/mm
2
 in 
2 g/l gelatin-coated FALCON polystyrene dishes in the presence of 10 M BrdU, to 
prevent the proliferation of non-myocytes. After 24h, the media was changed to remove 
BrdU from the culture. After 96h of culture, the CMs are treated with the respective 
calcium channel blockers or hypertrophic stimuli at a specific concentration, mentioned in 
the table 1, for 24 h. 
Where indicated, hypoxia (0.2% O2, 93% N2, 5% CO2) was achieved using an In Vivo2 
hypoxic workstation (Ruskin Technologies, Leeds, UK), after depriving the media of 
serum and glucose. 
All procedures involved in obtaining CMs from the animals were performed in this study 
followed National Institute of Health Guide for the Care and Use of Laboratory Animals.  
 
2. Cell Viability test 
 
2.1. TUNEL assay 
Cardiomyocytes were checked for viability upon calcium channel blockade by TUNEL 
assay using the In-situ cell death detection kit (Roche). The cells were plated in M24 
plates and after 96h they were treated with T-type and L-type Calcium channel 
antagonists and after 48h treatment were fixed with 4% Paraformaldehyde (PFA) for 20 
min at RT. After rinsing with PBS, the cells were permeabilized with a solution 
containing 0.1% Sodium citrate and 0.1 % Triton in PBS. The cells were then incubated 
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with the TUNEL reaction mixture containing TdT (enzyme solution) and fluorescein-
dUTP in 1:10 ratio for 1h at 37º C in a dark humid chamber, according to the 
manufacturer’s instructions. Subsequently, the cells were washed and stained with 
Hoechst and mounted with mowiol. During this incubation period, TdT catalyzes the 
addition of fluorescein-dUTP at free 3'-OH groups in single- and double-stranded DNA. 
After mounting, the cell viability was assessed by counting the TUNEL positive and 
TUNEL negative nuclei using fluorescence microscopy. 
 
3.  Auto-fluorescence assay 
 
In this study, acidic organelles were labeled with Monodansylcadavarine (MDC) and 
LysoTracker® Red DND-99 (LR), as per manufacturer’s instructions.  
 
3.1. Monodansylcadavarine  
 
Acidotropic labeling allows the observation of autophagosome formation in live cells. 
Autophagy can be quantified based on the number of MDC-positive vesicles per cell or 
the percentage of cells with MDC-positive vesicles. The cells were seeded in M24 plates. 
After 48 h of treatment with specific calcium channel inhibitor, the cells were incubated 
with Hoestch (10 μg/ml) in culture media for 5 mins. The cells were then washed with 
warm PBS 1X and incubated with MDC in the culture media at a final concentration of 
100 μM for 45 min in dark at 37ºC. After incubation, the cells were washed three times 
with PBS 1X and are observed for autophagic vacuoles under fluorescence microscope 
(excitation wavelength 380-420nm).  
 
3.2. LysoTracker® Red DND-99 
 
Weak basic amines selectively accumulate in the cellular compartments with low internal 
pH and the acidotropic labeling can be used in the investigation on biosynthesis and 
pathogenesis of lysosomes. In this experiment, the cells that were plated in M24 plates 
were incubated with Hoestch after 48h treatment as mentioned above for MDC labeling. 
After 5 min of Hoestch, the cells were washed with PBS 1X and incubated with 
LysoTracker® Red DND-99 at a final concentration of 100nm in culture media for 10 
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min. After incubation, the cells were washed thrice with PBS 1X and were observed for 
acidotropic labeling under fluorescence microscope in the presence of Tyrode solution.  
 
4. Western blot analysis  
 
At the end of the corresponding treatments, the CMs were washed twice with cold PBS. 
The corresponding CMs lysates were obtained by adding adequate lysis buffer [2% 
Sodium dodecyl sulphate (SDS), 125 mM Tris-HCl, pH 6.8], depending on the nature of 
the experiment. Protein extracts were denatured by heat shock at 95ºC for 3 min and 
quantified by a Lowry assay (Bio-Rad). Equal amounts of proteins were subjected to 
SDS–polyacrylamide gel electrophoresis (PAGE) and transferred to polyvinylidene 
difluoride membranes (Millipore, Bedford, MA, U.S.A.) using semidry Trans-Blot 
apparatus (Hoefer, Amersham Pharmacia Biotech). Non-specific binding was blocked by 
incubation with TBST (20 mM Tris-HCl, 150 mM NaCl, 0.1% Tween-20, pH 7.4) plus 
5% nonfat milk. Immunodetection was performed using the appropriate primary 
antibodies given in the table 3. Immunoblots were developed with an appropriate 
secondary Peroxidase-conjugated antibody, and the bound antibody was visualized using 
the chemiluminescent substrate Super Signal (Thermo Scientific, Rockford, U.S.A.) and 
EZ-ECL (Biological Industries, Israel). Levels of -actin (CMs) signal as well as 
Naphthol blue were used to verify equal protein loading in each lane. 
 
5. Gene knockdown by siRNA 
 
Briefly, CMs were plated at 80% confluence. 48h after seeding the cells, transfection was 
performed in serum free DMEM low glucose medium along with OptiMEM

 medium 
containing 50-100 nM siRNA and Lipofectamine RNAiMAX reagent (Invitrogen) 
following the manufacturer’s instructions. After 6h the medium was topped up with 
DMEM low glucose medium and 10% horse serum and 5% foetal calf serum without 
antibiotics. Cells were processed after 48h of transfection. In each experiment, the 
efficiency of knockdown was analysed by qPCR. The sequence of short interfering RNA 
is given in table 4.  
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6. Polymerase chain reaction 
 
The polymerase chain reaction (PCR) technique is applied for rapid enzymatic 
proliferation of a given segment of DNA. In this study, reverse transcription, semi-
quantitative and real time qPCR techniques were employed.  
 
6.1. Isolation of RNA and cDNA synthesis 
 
The total RNA was prepared from the treated CMs using Macherey-Nagel Total RNA 
and protein isolation kit, coupled with rDNase digestion, to prevent genomic DNA 
contamination, according to the manufacturer’s instructions. The concentration of RNA 
was determined by a Nanodrop (ND-1000) spectrometer. The cDNA synthesis was 
performed by reverse transcribing mRNA using Taqman Reverse Transcriptase enzyme 
(Applied Biosystems, Carlsbad, CA, USA). Negative control (RT-) was maintained to 
make sure that the target RNA was not contaminated with genomic DNA.  
 
6.2.  Semi-quantitative PCR 
 
The synthesised cDNA was used as a template for subsequent PCR amplification of 
specific VGCC pore-forming subunits. Primers were designed to be complementary to the 
published sequences of each of the VGCC pore-forming subunits, and also some 
sequences were obtained from the published literature. The housekeeping gene GAPDH 
was used as a loading control. The primers, sequences, product sizes and amplification 
conditions are mentioned in Table 5. 20 L of reaction mixture contained 10x reaction 
buffer (2L), 1.25μL MgCl2 (25mM), 1µL dNTPs (10mM), sterile water (22.55µL) and 
Taq polymerase (0.2μL). The PCR reaction was run in a thermocycler (Gene Amp® PCR 
System 2700 from Applied Biosystems). 38 cycles of PCR amplification include 
initialization at 95
◦
C for 5 minutes, denaturation at 94
◦
C for 30 seconds, annealing 
(temperature as mentioned in table 5) for 30 seconds, elongation at 72
◦
C for 30 seconds 
and final elongation at 72
◦
C for 7 minutes. Equal volumes of PCR products (20μL) were 
loaded and electrophoresed in a SYBR Safe (Life Technologies)-stained 3% agarose gel. 
The images of agarose gel illuminated by UV light were taken using Kodak EDAS 290 
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imaging system with Kodak 1D 3.6 software. Experiments were performed in triplicates 
and the representative images were presented.  
 
6.3. XBP1 splicing assay 
 
Under endoplasmic reticulum (ER) stress conditions, XBP1 mRNA is processed by 
unconventional splicing and translated into a functional transcription factor
178
. The 
procedure for XBP1 splicing assay was adapted from previous literature
179
. The sequence 
of the XBP1 primer is given in Table 5. The PCR product was amplified upto 35 cycles 
including initialization at 94
◦
C for 4 minutes, denaturation at 94
◦
C for 10 seconds, 
annealing at 63
◦
C for 30 seconds, elongation at 72
◦
C for 30 seconds and final elongation 
at 72
◦
C for 10 minutes. XBP1 processing is characterized by excision of a 26-bp sequence 
from the coding region of XBP-1 mRNA. To distinguish the unspliced from the spliced 
band, the PCR product was digested with Pst-1 for 2.5 h at 37ºC, because the cleaved 
product contains a Pst-1 restriction site. The resulting digests were run on a 3% agarose 
gel, to resolve the two digested products of length 290 bp and 183 bp. In contrast the 
products amplified from spliced XBP-1 mRNA were resistant to digestion and remained 
473 bp long. 
 
6.4.  Quantitative PCR (Real Time PCR) 
 
Predesigned gene-specific primer
 
pairs and probes were selected for one target gene 
(GADD153, GRP78, XBP1, Beclin1, Atg5, Atg12)
 
and a endogenous control (β-actin) 
within a list of predesigned
 
assays (Assays-on-Demand; Applied Biosystems). The 
relative quantification study was performed using TaqMan universal PCR master mix in 
an ABI prism 7000 sequence detection system (Applied Biosystems). This complete 
realtime PCR system enables detection and absolute quantification of nucleic acid 
sequences, by cycle-by-cycle detection of accumulated PCR products facilitated by 
detecting the changes in fluorescence signalling during the amplification. The qPCR 
allows the detection of PCR amplification in the exponential growth phase of a reaction. 
All assays were based on TaqMan hydrolysis probes labelled with FAM (green 
fluorescent fluorophore 6-carboxyfluorescein). The PCR reaction was performed with 
1L of cDNA for 40 cycles at 95ºC for 15 seconds and 60ºC for 1 minute. The results 
were obtained in the form of a Ct value (cycle threshold), which represents the cycle 
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number of the PCR during which the exponential growth of PCR product starts. 
Therefore, the higher the expression of the gene in the sample, the lower Ct value will be 
obtained as a result. The relative quantity of mRNA for every gene was calculated in the 
following manner: ∆Ct=Ct of the target gene - Ct of GAPDH gene; ∆(∆Ct) = ∆Ct of 
sample - ∆Ct of the control. Relative mRNA levels were calculated and expressed as fold 
induction over contralateral controls (value=1.0) following the formula 2
-∆(∆Ct)
. Every 
experiment was repeated three times and all samples were amplified in triplicates and 
data were normalized using GAPDH as endogenous control.  
 
7. Transfection with ptfLC3 plasmid 
 
The ptfLC3 is a tandem flagged plasmid construct obtained as a gift from Dr. Tamotsu 
Yoshimori. This plasmid contains the green fluorescent protein pEGFP-LC3 and the red 
fluorescent protein mRFP-LC3. The cells were seeded in 24 well plates with the normal 
culture media and after 24h the cells were transfected with OptiMEM

 medium 
containing 1 μg of the plasmid and Lipofectamine 2000 (Invitrogen). The media was 
replaced by normal culture media after 6h of transfection. The cells were left overnight in 
the incubator, and after 24h of transfection, the cells were treated and observed for 
evaluation of the autophagy flux from the co-localisation of both pEGFP-LC3 and mRFP-
LC3, at different time intervals of 4, 8 and 24h, under fluorescence microscope.  
 
8.  Statistical analysis 
 
Statistical significance was evaluated by Student’s t-test or by one- way ANOVA, as 
appropriate. Values of P< 0.05 were considered statistically significant. All data 
examined were expressed as mean ± standard error of the mean (SEM). 
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1. Introduction  
 
Voltage-gated Ca
2+
 channels that are widely distributed throughout the myocardium play 
a very important role in the proper development and functioning of the heart. During a 
cardiac action potential, Ca
2+
 influx through L-type Ca
2+
 channels enables Ca
2+
 loading 
into the sarcoplasmic reticulum and also triggers Ca
2+
 release from the SR enabling EC 
coupling. L-type Ca
2+
 channels are considered to be the key target to regulate inotrophy 
in the treatment of cardiovascular diseases. Ca
2+
 entry through the T-type Ca
2+
 channels 
plays an important role in the development of heart throughout the neonatal period and 
also modulates the pacemaker activity
180
. T-type channels disappear during the end of the 
neonatal period, and are known to be re-expressed in the adult CMs under pathological 
conditions.  
L-type and T-type Ca
2+
 channel antagonists are known to be potent vasodilators and have 
been widely used in the treatment of various cardiovascular diseases such as 
hypertension, coronary artery disease, angina, hypertrophic cardiomyopathy, and others. 
The dihydropyridines nifedipine and nimodipine, which are potent L-type channel 
blockers, and the non-dihydropyridines mibefradil and bepridil, as T-type channel 
blockers, were used in this study.  Particularly, mibefradil was initially identified as a 
dual T/L type Ca
2+
 channel blocker. Later, studies have shown that mibefradil blocks T-
type channels with higher sensitivity of 10 to 30 fold over L-type channels
181-182
.  
This chapter deals with the effect of pharmacological blockade of T- and L-type VGCC 
on cell viability and on the disruption of Ca
2+
 homeostasis, and the possible outcomes of 
the unfolded protein response and/or deregulation of the autophagic flux in neonatal CMs.  
 
2. Results: 
 
2.1. Expression of L-type and T-type Calcium channels in ventricular CMs 
 
Molecular cloning studies have revealed 10 genes encoding pore-forming α1 subunits. 
These 10 genes are classified into 3 major families based on their sequence similarity. 
The HVA channels comprise the L-type channels (Cav1.1–1.4), and the P/Q- (Cav2.1), N- 
(Cav2.2) and R- (Cav2.3) type channels. The LVA channels form the third family 
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comprising the T-type channels or Cav3.x family. Out of these, it has been shown 
previously that the L-type channels Cav1.2 and Cav1.3, as well as the T-type channels 
Cav3.1 and Cav3.2, are expressed in neonatal CMs. We performed a series of PCR 
reactions to check the expression of T-type and L-type channels in our cell model of rat 
ventricular neonatal CMs. The cDNAs obtained from the CMs were amplified with the 
specific primers for the VGCC pore-forming subunits and the PCR product was run on a 
3% agarose gel. We found that the four channel types namely Cav3.1, 3.2, Cav1.2 and 1.3 
are expressed in the neonatal CMs as previously reported (Figure 1). 
 
                    
 
Figure 1:  RT-PCR to check the expression of the VGCC pore-forming subuints in 
neonatal rat ventricular CMs. As reported previously, Cav3.1, Cav3.2, Cav1.2 and Cav1.3 
are expressed in CMs.  
 
2.2. Effects of VGCC blockers on the viability of CMs 
 
Apoptosis and necrosis play a key role in the pathogenesis of cardiovascular diseases. 
Cell death resulting from apoptosis is due to the loss of terminally differentiated CMs and 
it can be mediated by the apoptotic death receptors in the plasma membrane, as well as 
due to the release of apoptotic factors from mitochondria. Many factors such as stress 
proteins, growth factors and intracellular Ca
2+
 levels are known to regulate apoptotic cell 
death 
183
. Therefore, we wanted to study the effect of VGCC blockers on the viability of 
CMs.  
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Figure 2: Viability of CMs in the presence of T-type and L-type calcium channel 
blockers. A) The fluorescent microscopy images show the effect of the drugs on the 
viability of cells, the dead cells represented by TUNEL positive cells along with pignotic 
nuclei (revealed by Hoechst staining). B) The percentage of death induced by the T-type 
and L-type channel blockers compared to the control.   
 
The cells were treated with the L-type and T-type channel blockers, along with 
thapsigargin and deprivation as positive controls, for 48 hours. The DNA fragmentation 
induced by the VGCC blockers was studied using TUNEL immunostaining assays. We 
found that the L-type channel blockers (nifedipine and nimodipine) significantly 
increased the TUNEL positive cells, with nifedipine decreasing the viability of CMs to 
50%, which was higher than that of thapsigargin and deprivation (~30%) (Figure 2A). 
However, neither T-type Ca
2+
 channel blocker mibefradil nor bepridil did significantly 
decrease the viability of CMs when compared to the untreated controls (Figure 2 B).  
 
2.3. VGCC blockers induce a transient unfolded protein response 
 
Ca
2+
 entering through the L-type Ca
2+
 channels regulates Ca
2+
 loading in the SR and 
subsequent EC coupling in CMs. Thus, we reasoned that disturbance in the Ca
2+
 influx 
via L-type channels would lead to disruption of the Ca
2+
 homeostasis in ER, leading to 
ER stress. A sustained ER stress induces the Unfolded Protein Response (UPR).  We thus 
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proceeded to the analysis of three main UPR markers, namely the molecular chaperone 
GRP78 and the transcriptional regulators GADD153 and XBP1.  
Induction of UPR upon treatment of CMs with L-type and T-type Ca
2+
 channel blockers 
was studied by checking the expression of these three UPR markers, by q-PCR, RT-PCR 
and western blot, at two different time points (8h and 24h).   
The q-PCR experiments to quantitate the expression of three UPR genes showed a low 
level upregulation of the 3 genes at 8h by application of both L-type and T-type channel 
blockers (Figure 3A). This UPR induced by both type of channel blockers was of a 
transient nature, as the expression of two of the UPR genes, XBP1 and GRP78 dropped 
down to near control levels at 24h (Figure 3 B), whereas that of GADD153 was 
maintained only upon T-type channel blockade. In contrast, the positive controls, 
thapsigargin and deprivation showed a sustained upregulation of all the three UPR genes.  
 
 
   
Figure 3: Transient UPR induced at 8h, comes down to normal levels at 24h. A) Low 
level UPR is induced at the transcriptional level at 8h by T-type and L-type channel 
blockers. B) The transient UPR induced by the T-type and L-type channel blockers 
dropped down to near control levels at 24h. C) Western blots at 8h show induction of 
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both GADD153 and GRP78. β- actin is used as a house-keeping control in q-PCR 
experiments.   Histogram bars represent mean ±SD values from at least 5 independent 
experiments *Significant differences related to untreated control, P< 0.05. 
 
The detection of protein levels by WB assays confirmed the induction of UPR, showing 
moderate GADD153 and GRP78 upregulation at 8h treatments with L-type and T-type 
channel blockers, in contrast with a stronger and sustained upregulation by thapsigargin 
and deprivation treatments (Figure. 3C).  
 
2.4. The number of acidic organelles and autophagic vacuoles increases in the 
presence of VGCC blockers 
 
It has been shown that a sustained UPR may either lead to cell death by apoptosis or cell 
survival by autophagic clearance of accumulated unfolded proteins. Also, previous 
studies have shown that ER stressors induce the formation of autophagosomes that can be 
observed at the ultrastructural level
169
. We wanted to study if the UPR induced by L-type 
and T-type Ca
2+
 channels could in turn trigger a macroautophagic process. Initially, we 
studied this issue by labelling the CMs with autofluorescent acidotropic compounds like 
LysoTracker® Red DND-99, targeting acidic organelles, and MDC (monodansyl 
cadaverine) which accumulates in autophagic vacuoles.   
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Figure 4:  Increased acidotropic labelling induced by both T-type and L-type calcium 
channel blockers. A) Lysotracker red assay under fluorescent microscopy showing 
increased acidotropic staining in cells treated with L-type or T-type calcium channel 
blockers, compared to untreated cells. B) MDC, targeting autophagic vacuoles, also 
displayed an increased staining in CMs subject to treatment with L-type and T-type 
channel blockers. Note that addition of vATPase inhibitor bafilomycin prevented any 
Lysotracker red or MDC staining. C) The transmission electron microscopy photographs 
reveal amphisomes (AM) with mibefradil treatment, autophagosomes (AP) with 
nifedipine. Thanpsigargin treatment resulted in swollen ER. The images are 
representative of at least 3 independent experiments with duplicates for each individual 
treatment.  
 
We found that the L-type and T-type channel blockers induced a strong acidotropic 
labelling by both MDC and LR, CMs displaying a punctate fluorescent pattern at 400x 
optical magnification (Figure. 4). In comparison, deprivation of CMs increased the level 
of LR and MDC labelling to a lesser extent, whereas the fluorescence levels for both dyes 
were below those of control when the cells were incubated with autophagy inhibitor 
thapsigargin. 
To complement the fluorescence experiments referred above, we examined CMs 
ultrastructure by transmission electron microscopy, which remains an utmost reliable 
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method to detect alterations in the autophagic flux, while not readily quantifiable
184-185
. 
The cytoplasm of CMs treated with mibefradil (or bepridil, not shown) was plagued with 
amphisomes/MBVs, as evidenced by the presence of large electrondense double-
membrane vacuoles with mitochondria and other cellular organelles inside (Figure 4 C). 
In contrast, the cytoplasm of CMs treated with L-type channel blocker nifedipine (or 
nimodipine, not shown) displayed numerous double-membrane autophagic vacuoles 
surrounding diverse cytoplasmic components, compatible with autophagosomes. The 
cells treated with thapsigargin displayed swollen ER. 
 
2.5. Autophagy is differentially regulated by T-type and L-type calcium channels 
 
We studied the autophagic process in CMs at the molecular level by analyzing the 
expression of 3 key mediators of canonical macroautophagy at the transcriptional level by 
q-PCR, using specific probes for the inducible genes Beclin1 (Atg6), Atg5 and Atg12. At 
the peak of the UPR  (8 h), none of VGCC blockers had induced the expression of Atg 
genes significantly. However, there was a significant upregulation of Atg5 and Atg12 
genes at 24 h, displaying a nearly 2-fold induction with respect to control cells. Like for 
UPR genes, these increases were moderate compared to those induced by deprivation or 
thapsigargin (Figure 5A, B). At the protein level, the WB results at 24 h treatments show 
that L- and T-type channel blockers  increased the levels of autophagosome 
nucleation/initiation protein Beclin1, but not Atg5 or the tandem Atg5-Atg12, opposite to 
the effects of deprivation, that surprisingly decreased the lebels of all analyzed Atgs 
(Figure. 5C).  
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Figure 5: The expression of Atg genes is induced by T-type and L-type channel blockers 
at the transcriptional and protein level. A) q-PCR analysis of the cells treated with the 
drugs does not show any significant increase of Atg genes compared to that of 
thapsigargin and deprivation at 8h. B) Only the treatments with T-type channel blockers 
show a little induction of Atg5 and Atg12 genes at 24h. C) Western blot analysis at 24h 
shows increase of only Beclin1 but not Atg5 with both the T-type and L-type channel 
blockers. β- actin is used as a house-keeping control  Histogram bars represent mean 
±SD values from at least 5 independent experiments *Significant differences related to 
untreated control, P< 0.05. The western blots are representative of at least five 
independent experiments. 
 
We also performed WB assays to quantify the conversion of LC3 (Atg8) from the soluble 
form (LC3-I) to the autophagosomal-associated lipidated form (LC3-II). 
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We could observe a robust LC3 conversion to its lipidated form (LC3-I to LC3-II) due the 
effect of L-type and T-type channel blockers, such that the LC3II/I ratio values displayed 
the following order, from highest to lowest: mibefradil> deprivation> nifedipine> 
thapsigargin> nimodipine> bepridil > control (Figure 6 A,B). Based on the level of LC3-
II conversion and also the differential effect of the drugs on the viability of the cells in 
TUNEL assay, mibefradil and nifedipine were chosen for further comparative studies on 
the effect of T-type and L-type Ca
2+
 channel blockers on CMs autophagy.  
As the LC3-II ratio provides information only about the number of autophagosomes
186
 
but is not indicative of their biogenesis, the autophagic flux can be more accurately 
studied in the presence or absence of lysosomal protease inhibitors or Bafilomycin A1, 
which is a v-ATPase inhibitor thus preventing autophagosome-lysosome fusion. Increase 
in autophagic flux as a result of a pharmacological challenge can be interpreted from the 
further increase in LC3-II ratio upon addition of Bafilomycin A1, whereas an unaltered 
LC3-II ratio upon addition of Bafilomycin A1 is interpreted as inhibition of autophagy 
and accumulation of autophagosomes
187
.  
To distinguish between these two possibilities, we applied a selection of the usual 
treatments in the absence or presence of bafilomycin A1, which is a stablished inhibitor of 
autophagosomal-lysosomal fusion. In the treatment with L-type channel blocker 
nifedipine, the LC3II/I ratio was largely increased by co-application of Bafilomycin A1. 
In contrast, in the treatments with T-type channel mibefradil or thapsigargin, the intensity 
of the LC3II band was not further increased by bafilomycin, indicative of a suppression 
of autophagy rather than an enhancement of lysosomal clearance (Figure. 6C). 
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Figure 6: Autophagy is differentially regulated by T-type and L-type Ca
2+
 channel 
blockers. A) Both at 8h and 24h, both T-type and L-type channel blockers increase the 
conversion of LC3-I to its lipidated form LC3-II. B) The ratio of LC3-II/LC3-I in the 
presence of drugs shows a higher conversion with mibefradil 10µM and a moderate 
increase with nifedipine 10µM and nimodipine 10µM. C) Co-application of bafilomycin 
A1 does not increase the LC3-II conversion ratio due to mibefradil any further, but it 
does for nifedipine.  D) Mibefradil 10 µM promotes the accumulation of p62/SQSTM1 
and ubiquitin aggregates whereas nifedipine 10 µM induces a decrease in both 
p62/SQSTM1 and ubiquitin aggregates. These western blots are representative of at least 
five independent experiments. Histogram bars represent mean ± SD values from at least 5 
independent experiments *Significant differences related to untreated control, P< 0.05. 
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The autophagic flux is reflected in the degradation and autophagic clearance of 
ubiquitinated proteins and is better studied by the involvement of p62/SQSTM1. During 
autophagy stimulation, p62/SQSTM1 is degraded since the interaction of LC3-II with 
p62/SQSTM1 targets ubiquitin-conjugated protein for turnover, and p62/SQSTM1  
becomes an autophagy substrate along the aggregates 
188
. Conversely, autophagy 
inhibition results in the accumulation of p62/SQSTM1proteins. 
Examination of p62/SQSTM1 protein expression by western blot showed that, at 24 h, the 
L-type channel blocker nifedipine significantly decreased the intensity of the 
p62/SQSTM1 band, which was otherwise increased by treatment with the T-type channel 
blocker mibefradil. Western blot results with a monoclonal antibody against ubiquitin 
were consistent with the p62/SQSTM1 band intensity variation: whereas nifedipine either 
decreased or maintained the ubiquitin intensity, mibefradil increased ubiquitin labelling in 
the entire lane when compared to the untreated control (Figure 6 D). The application of 
thapsigargin also increased the p62/SQSTM1 and ubiquitin aggregates, whereas 
deprivation of the CMs maintained or increased both labels at 8 and 24 h time points.  
 
2.6. Autophagic flux accessed by tandem flagged LC3 constructs 
 
We wanted to confirm the results described above by transfecting in CMs the pft-LC3 
tandem construct, in which LC3 is tagged with both green fluorescent protein) GFP and 
monomeric red fluorescent protein (mRFP). The GFP helps in the localization of LC3 and 
has been widely used as an autophagosome marker. Whereas the GFP fluorescence is lost 
under acidic conditions and is degraded by lysosomal hydrolases, the mRFP fluorescence 
remains stable
189-190
.  
CMs were plated in M24 wells, and after 24h of culture, they were transfected with 
plasmids encoding ptf-LC3 in the presence of Lipofectamine 2000. After 24 h of 
transfection, the cells were treated with mibefradil and nifedipine along with rapamycin 
(100 nM) or Hanks buffer as positive controls of autophagy flux, and bafilomycin A1 
(5nM) as an autophagy inhibitor. The cells were observed under fluorescence microscopy 
after 24h of treatment. The yellow puncta that is observed upon merging green and red 
images indicates autophagosomes and the red puncta indicates autophagolysosomes
191
. 
Thus, the increase in both yellow (a merger of GFP and mRFP in autophagosomes) and 
red puncta (mRFP in autolysosomes) is indicative of an enhanced autophagic flux, 
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whereas the increase of yellow (but not red) puncta indicates inhibition if autophagy
192-
193
.   
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Figure 7:  Determination of autophagic flux using tandem flagged LC3. A) Mibefradil 
10µM induced an increase in the ratio of yellow to red puncta, indicating inhibition of 
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autophagy, whereas nifedipine 10 µM induced an increase in red over yellow puncta, 
indicative of autophagy induction. The autophagy inducer rapamycin induced an increase 
in the number of red puncta, whereas the autophagy inhibitor bafilomycin A1 induced an 
increase in the number of yellow puncta. B) A graphical representation of the percentage 
of fluorescent structures present inside the cells 48h after transfection with ptfLC3, which 
includes 24h of treatment with VGCC blockers post transfection. 
 
In our experiments we found that mibefradil increased the ratio of yellow over red puncta 
drastically at 24h, whereas nifedipine exerted the opposite effect (Figure 7). The results 
attained by treating the CMs with mibefradil were similar to those obtained using 
bafilomycin A1. Conversely, the results from nifedipine treatments were consonant with 
rapamycin-treated CMs. These data, in accordance with the western blot results in the 
presence of bafilomycin and also with the p62/SQSTM1 and ubiquitin western blot data 
clearly indicates an opposite effect of T-type and L-type Ca
2+
 channel blockers on 
macroautophagy in CMs.  
 
2.7. Comparison of pharmacological blockade and gene silencing of VGCCs 
 
In order to confirm that the pore-forming subunits of the L-type and T-type channels were 
the real molecular targets of the pharmacological blockers, we wanted to check the 
expression of UPR genes and assess the autophagic flux in CMs subject to VGCC 
knockdown with the RNAi technique. RNAi helps in the understanding of the functional 
role of a specific gene by specific gene silencing. siRNAs (small interfering RNAs) were 
designed specifically for the individual Ca
2+
 channel isoforms, namely T-type Cav3.1, 
Cav3.2 and L-type Cav1.2 and Cav1.3, channels, encoded by the genes Cacna1g, Cacna1h, 
Cacna1c and Cacna1d respectively. 
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Figure 8: Knockdown efficiency of the gene specific siRNA. q-PCR results obtained after 
gene silencing by using specific probes for the genes encoding the T-type and L-type 
calcium channels showed that the silencing of the channels induced a significant 
knockdown of the specific genes, ranging from 60% to 95%. β- actin was used as a house-
keeping control. Histogram bars represent mean ±SD values from at least 5 independent 
experiments *Significant differences related to untreated control, P< 0.05.  
 
After 48h in culture, the CMs were transfected with siRNA specific for T-type and L-type 
Ca
2+
 channels and the effects of knockdown on UPR and autophagy were elucidated by q-
PCR and western blot assays. 48h after transfection, the efficiency of the knockdown was 
measured by using the q-PCR technique and the results showed a transfection efficiency 
ranging from 95% (Cav1.3) to 60% (Cav3.2) (Figure 8). Importantly, the q-PCR results 
also showed that upon knockdown of one channel type, the expression of others is 
upregulated. For instance, the knockdown of Cav3.1 resulted in the upregulation of the 
expression of both Cav3.2 and Cav1.3; in a similar way, Cav3.2 knockdown resulted in the 
upregulation of Cav3.1 and Cav1.3. Co-transfection of Cav3.1 and Cav3.2 siRNA resulted 
in a 50% knockdown of both the channels and a near 2-fold increase in Cav1.3 
expression. The knockdown of Cav1.2 channels exacerbated the expression of all other 
Ca
2+
 channels, whereas the knockdown of Cav1.3 increased the expression of only T-type 
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Cav3.1 and Cav3.2 channels. Here also, co-transfection of Cav1.2 and Cav1.3 rendered a 
65-70% knockdown of both channels and resulted in a 1.5 to 3-fold induction of T-type 
Ca
2+
 channel expression. Thus, our data indicated that the expression of the different 
VGCC types in CMs is regulated in a concerted manner, so that compensatory 
mechanisms are unleashed upon knockdown of specific isoforms. 
We performed XBP1 splicing assay for the knockdown samples. XBP1 mRNA is 
processed by unconventional splicing and translated into a functional transcription 
factor
178
. In our experiments the knockdown of Cav3.1 or Cav3.2 induced a moderate 
splicing of XBP1 splicing that did not occur with the knockdown of Cav1.2 or Cav1.3 
(Figure 9A).  
Western blot results were unconsistent for GRP78, but showed a steady upregulation of 
GADD153 upon knockdown of all channel types (Figure 9B).  
 
 
 
Figure 9: Monitoring UPR by gene silencing. A) The XBP1 splicing assay show a 
stronger intensity of the upper band (sXBP1) due to the knockdown of Cav3.1 and Cav3.2 
channels, in contrast with a lack of effect for the knockdown of Cav1.2 or Cav1.3. B) The 
western blot results show unconsistent results for GRP78, but a clear increase of 
GADD153 protein expression due to the knockdown of all VGCC genes.The western blots 
are representative of at least five independent experiments. 
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Figure 10:  Autophagic flux upon silencing the channels.  Western blots results 
displaying the de-regulation of autophagy due to VGCCs gene silencing. The knockdown 
of Cav3.2 mimicked the effects of mibefradil, whereas the knockdown of Cav1.2 or Cav1.3 
channels also increased the p62/SQSTM1 and ubiquitin band intensities, contradictory to 
the pharmacological blockade of L-type Ca
2+
 channels. The western blots are 
representative of at least five independent experiments. 
 
The analysis of LC3 by western blot showed an increased LC3-II conversion due to the 
knockdown of Cav1.2, Cav1.3 and Cav3.2 channels. In an apparent contradiction with the 
pharmacological data, the knockdown of L-type Ca
2+
 channels increased the 
accumulation of p62/SQSTM1 and ubiquitin aggregates. The knockdown of Cav3.2 also 
increased p62/SQSTM1 levels and ubiquitination of protein aggregates, in good 
correlation with the data provided by mibefradil treatment (Figure 10).   
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2.8. Effect of VGCC blockers at therapeutic concentrations 
 
In an attempt to shed light to the contradictory results of L-type channels pharmacological 
blockade and gene silencing on autophagy regulation, we performed a series of 
experiments to compare the effects of T-type and L-type channel blockers applied at high 
and low concentrations. The rationale was that, at lower concentrations, the putative 
overlap between the two drugs would be reduced as the target specificity would be 
increased. 
The cells were treated with mibefradil and nifedipine at a concentration of 1µM (close to 
the concentration achieved in the blood of human patients, i.e. therapeutic concentration) 
for 24h, along with the drugs at 10 M and thapsigargin as a positive control for UPR 
induction, and the results were analysed by western blot assay.  
 
 
 
Figure 11: Comparison of the effects of 2 different concentrations of drugs. A) Mibefradil 
and nifedipine only increased the protein band for GRP78 at the concentration of 10 M 
(see the top band). The band corresponding to GADD153 shows clear increases with both 
drugs at 1 and 10 µM concentrations. B) The XBP1 splicing assay also shows the 
absence or a low level splicing with both nifedipine 1 µM  and 10 µM, whereas splicing is 
induced by mibefradil 10 M. C)Mibefradil and nifedipine at both concentrations 
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induced LC3 II conversion. Mibefradil at 1 µM induced a slight increase in p62/SQSTM1 
which was further increased by the higher concentration, while nifedipine did not induce 
an increase of p62/SQSTM1 at both lower and higher concentrations. The western blots 
are representative of at least five independent experiments. 
 
Our data showed that T-type and L-type Ca
2+
 channel blockers at 1 µM had the same 
qualitative effect on the expression of UPR and ATG genes measured at the protein level, 
as that of 10 µM, but with less intensity. One of the UPR markers GADD153 was found 
to be induced with 1 µM and 10 µM of both mibefradil and nifedipine. The levels of 
GRP78 were moderately increased only at 10 M treatments (Figure 11A). This could be 
due to the feedback mechanism activated that controls GRP78/BiP levels at a translational 
level
194
. The XBP1 splicing assay showed an increased splicing with respect to control 
with both concentrations of mibefradil, whereas both concentrations of nifedipine were 
refractory to induce XBP1 splicing in correlation with L-type Ca
2+
 channels knockdown 
(Figure 11B).  
Mibefradil and nifedipine both at high and low concentrations increased the expression of 
Beclin1. In contrast, the expression of Atg5 and formation of the Atg5-Atg12 complex 
was increased by nifedipine at 1 M, and surprisingly reduced by nifedipine at 10 µM 
concentration (Figure 11C).  
In the case of LC3, mibefradil and nifedipine induced LC3-II conversion at both 1 µM 
and 10 µM concentrations, with mibefradil 10 µM showing a higher ratio of conversion. 
The band for P62/SQSTM1 was increased upon treatment with mibefradil 1 µM, being 
the effect further enhanced at 10 µM. In clear contrast, treatment with nifedipine did not 
increase the intensity of the p62/SQSTM1 band at any concentration. The p62/SQSTM1 
results were in line with the level of ubiquitinated aggregates for both drugs. 
 
 
3. Discussion 
 
This chapter deals with the study of the effect of VGCC blockers on the viability and 
homeostasis of the neonatal rat ventricular CMs. The role of VGCC blockers in 
cardioprotection has long been reported and this study was intended to lay the grounds for 
a putative cardioprotective strategy.  
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The viability assays performed in the presence of the VGCC blockers showed at the first 
instance that the T-type and L-type channels affect the viability of the cells differently: T-
type channel blockers did not affect the viability of the cells in any direction, whereas the 
L-type channel blockers induced a higher degree of cell death (Figure 2).  
Since the main functions of endoplasmic reticulum are Ca
2+
-dependent, we set out to 
study the effect of blocking VGCCs on ER homeostasis. As expected (but not 
investigated previously), the pharmacological blockade of VGCCs induced the UPR in 
CMs. Clearly, this shows that Ca
2+
 influx through VGCCs plays an important role in the 
maintenance of Ca
2+
 homeostasis beyond its well-known role in E-C coupling. The UPR 
response induced by application of VGCC blockers was transient, as the maximum levels 
of induction of two of the UPR markers XBP1 and GRP78 at the RNA level was seen at 
8h, and reduced to near control levels at 24h with both T-type and L-type channel 
blockers. However, the higher level of GADD153 attained at 8h was maintained at 24h in 
the presence of T-type channel blockers. At the protein level, GRP78 showed a moderate 
increase upon 24 h treatment with either T-type or L-type Ca
2+
 channel blockers. Gulow 
et al.
194
 postulated that translational and transcriptional upregulation of GRP78 are 
independent events and also that there is a possible regulatory mechanism that acts in a 
stress-dependent manner and specifically controls GRP78/BiP expression at the 
translational level during UPR. The translational rate of GRP78 mRNA could be 
controlled either by some signalling by the protein or by some structural motifs present in 
the mRNA
194
. Another aspect deserving consideration is that mibefradil induced XBP1 
splicing whereas nifedipine did not.  Under prolonged ER stress, XBP1u operates 
negatively by enhancing XBP1s degradation, which may lead to termination of UPR
195
 . 
XBP1u is also shown to induce autophagy by regulating FOXO1 expression
196-197
. Thus, 
XBP1u may interconnect and regulate various homeostatic pathways in mammalian cells, 
by linking ER stress pathway and autophagy
198
. 
Both T-type and L-type channel blockers that induced a transient UPR also increased the 
presence of autophagosomes/autophagic vacuoles, in agreement with a previous study by 
Ogata et al. 2006
169
, showing that ER stressors induced the formation of autophagosomes. 
As a matter of fact autophagy is an important cell process utilized by the heart for the 
maintenance of cellular homeostasis in both basal and stressed conditions. Previous 
studies have reported that induction of autophagy in response to cardiac stress is essential 
for cardioprotection and for minimizing the myocardial damage
199-200
.  
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Our study of autophagy markers in the transcriptional and the protein level initially 
suggested that there could be an induction of autophagy by both T-type and L-type 
channel blockers. However, an increase in Atg12-Atg5 expression or induction of Beclin1 
does not give a complete picture of the autophagy status
188
. There are previous reports 
stating that in some mouse and human cancer cell lines, ER stress may increase the 
transcription of Atg5 and Atg12 in response to UPR
201
 . Initially, the LC3-II conversion 
induced by the drugs confirmed to us the deregulation of autophagy in CMs. In addition, 
our experiments in the presence of an autophagosome-lysosome fusion inhibitor 
suggested that the T-type channel blocker mibefradil inhibited autophagy whereas the L-
type channel blocker nifedipine enhanced autophagic flux. This result was further 
supported by monitoring p62/SQSTM1 levels and ubiquitin aggregates. Previous studies 
have shown that p62/SQSTM1 depletion decreases LC3-II
202
. Interestingly, studies from 
Bjorkov et al, also show that p62/SQSTM1 depletion leads to induction of cell death by 
polyglutamine
203
. Thapsigargin, a SERCA pump inhibitor and ER stress inducer, also 
induced an increase in the levels of p62/SQSTM1 and ubiquitin aggregates, thus 
appearing to block autophagy as previously reported by Ganley et al.
204
. Previous studies 
in mouse embryonic fibroblasts have also shown that thapsigargin inhibits 
autophagosome-lysosome fusion
205
. But the autophagic flux induced by deprivation 
switched from an increased autophagic flux to a decreased autophagic clearance from 
shorter to longer time points. After 24 h of deprivation the level of LC3-II was increased, 
but the levels of p62/SQSTM1 were not decreased and, in some cases, even augmented 
when compared to untreated control cells. Consistent with this, Ramirez-Peinado et al. 
reported that LC3-II accumulation in cells starved for a long time may mean that 
autophagy is reduced compared to basal autophagy
206
. A review by Klionsky and 
Nemchenko, suggests that this autophagic rollercoaster induced by deprivation is to 
maintain the autophagy at an optimal level and not excessive level, as excessive 
autophagy might be detrimental
207
. Also, a previous work from Komatsu et al. with 
p62/SQSTM1 deficient mice has shown that deprivation-induced-autophagy, being 
nonselective, does not require p62/SQSTM1 for autophagic clearance
208
.   
The application of VGCC blockers to CMs that had been transfected with ptfLC3 
plasmids showed an increase in mRFP labelling for nifedipine, and yellow puncta for 
mibefradil, reinforcing the concept that nifedipine enhances autophagy whereas 
mibefradil negatively regulates the autophagic flux.  
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The bacterial macrolide rapamycin is known to induce macroautophay by inhibiting 
mTOR activity. Previous reports indicated that rapamycin not only promotes formation of 
autophagosomes but also enhances autophagosome-lysosome fusion
209
. Hence, 
rapamycin is considered as one of the best positive controls to study autophagic flux via 
ptfLC3 experiments. In the presence of nifedipine a substantial population of tfLC3-
transfected cells displayed only RFP signal, indicating enhancement of autophagic flux. 
The results attained in these experiments point to a similar efficacy of rapamycin and 
nifedipine in increasing the red puncta in CMs.  
Our experiments dealing with VGCCs gene silencing were meant to shed light on the 
differential role of the Cav1 and Cav3 channels in Ca
2+
 homeostasis (and thereby on the 
regulation of macroautophagy), but proved not to be consistent with the pharmacological 
blockade data. The interpretation of these data is rather difficult, because of the incapacity 
to use a crucial assay to assess the autophagic flux; unfortunately and, given the technical 
impossibility of simultaneous gene overexpression and silencing, we could not perform 
the tfLC3 test in knocked-down CMs. Due to the fact that the p62/SQSTM1 gene may be 
induced to enhance cardiac autophagy
202
, it is not possible to conclude that an increase in 
p62/SQSTM1 protein is necessarily the result of autophagy inhibition. However, the 
concomitant increase in poly-ubiquitinated aggregates, strongly suggests that the increase 
in p62/SQSTM1 due to Cav3.2 and Cav1.2 knockdown is the result of lack of degradation. 
Thus, whereas gene silencing of T-type Cav3.2 channels was consistent with 
pharmacological data at all levels, that of L-type channels was unconsistent regarding the 
regulation of the autophagic flux. The interpretation of these experiments is further 
complicated by the unexpectedly found interrelationship between the different VGCC 
isoforms. In this regard, we believe that the cross-regulation displayed by the genes 
encoding VGCCs should be taken into consideration. As a matter of speculation, the 
seemingly inhibitory effect of Cav1.2 knockdown on autophagy could be due to the 
concomitant overexpression of Cav3 channels. Nonetheless, a corollary of these results is 
that both systolic Ca
2+
 influx through L-type channels and -presumably diastolic-Ca
2+
 
influx through T-type channels control Ca
2+
 homeostasis in neonatal CMs.  
Generally speaking, autophagy is regarded as a cell survival mechanism. Studies on 
diseases caused by protein aggregates like Huntington’s and parkinson’s disease point to 
ER-stress induced autophagy as a way to promote removal of protein aggregates and 
thereby enhance cell survival 
210
. In case of heart failure, the role of autophagy remains 
less clear or double edged. While some studies suggest that autophagy is beneficial, 
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others indicate that cardiac autophagy might be detrimental. The effect of autophagy on 
cardioprotection has been widely studied under various cardiomyopathies and it can be 
stated that impairment of autophagy contributes to morbidity and mortality associated 
with cardiovascular diseases
211
. Matsui et al. showed that autophagy was beneficial 
during ischemia and detrimental during reperfusion injury
143
. Zhu et al. postulated that 
increased autophagosome abundance in pressure-overload animals is a reflection of 
compensatory autophagy that becomes ineffective due to impairment of autophagic flux 
mediated by Beclin1
145
. They also concluded that autophagy negatively regulates cell 
size, antagonising cardiac hypertrophy, and also it is protective in some forms of 
cardiomyopathy like desmin-related cardiomyopathy and ischemia/reperfusion injury. 
Kanamori et al. investigated the function of autophagy in cardiac remodelling using a 
mouse myocardial infarction model. They found that blocking of autophagy with 
bafilomycin A1 exacerbated cardiac dysfunction, whereas enhancement of autophagy 
alleviated cardiac remodelling and dysfunction
212-213
. Gottlieb et al. also recently reported 
that upregulation of autophagic flux mitigates post-infarction remodelling
214
. Although all 
these cases clearly indicate that activation of autophagy might be cardioprotective, there 
are also reports that associate autophagy with progressive destruction of CMs in the 
failing heart. The hamster model of dilated cardiomyopathy studied by Miyata et al. 
revealed the presence of autophagy vacuoles and degraded mitochondria in the CMs 
under ultrastructural analysis. In this model, the heart failure was found to be progressive 
leading to 50% mortality at 30 weeks
215
. Wang et al. has shown that the induction of 
excessive autophagy in late-stage hypertrophy leads to cardiac failure
142
. Interestingly, 
experiments by Kinoshita et al. showed that T-type channel blockade prevents sudden 
death in heart failure mice by reducing arrhythmias in dilated cardiomyopathy
216
.  
In this line, our data suggests that the autophagy induced by pharmacological blockade of 
L-type channels might be detrimental, as it dramatically lowers the viability of cultured 
neonatal CMs. In open contrast, the pharmacological blockade of T-type channels seems 
to block the strong constitutive autophagy present in neonatal cells in a sustainable 
manner, ensuring cell viability 48 h into the treaments. 
T-type Ca
2+
 channels are sensitive to depolarization and they provide a transient current 
by activation and inactivation at a fast rate
29
. In addition, the steady-state activation and 
inactivation curves overlap, providing a constant inward window current which may 
facilitate slow diastolic depolarization contributing to automicity, and also help in Ca
2+
 
homestasis mantainance in the ER
217-218
. T-type channels are abundantly expressed in 
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embryonic and neonatal ventricles
180,218
, but in adult animals their expression in the heart 
is restricted to the conduction system
219-220
. Relevantly, T-type channels are however 
found to be re-expressed in the hypertrophied and failing hearts
78,221
.  The ICaT found in 
the pressure overload-induced hypertrophic heart is involved in pathological process that 
leads to systolic dysfunction and arrythmogenesis
78,216
.  Furthermore, Chiang et al. 
demonstrated that genetic deletion of CACNA1H rendered resistance to pathological 
cardiac hypertrophy.  The pharmacological blockade of T-type channels has also been 
shown to limit cardiac remodelling and improve the function or viability of heart cells 
subject to hypertrophic stimuli
220,222-223
 
224-225
 and post myocardial infarction
224
. In 
addition, Kinoshita et al. reported that the pharmacological blockade of T-type channels 
with mibefradil prevented sudden death induced by non-ischemic or ischemic myocardial 
injury. While blockade of T-type channels appears to be cardioprotective, previous 
studies from Hong et al. suggest that impairment of membrane trafficking of L-type 
Cav1.2 channels leads to heart failure
226
.  
Consistent with these reports our results show, for the first time, that pharmacological 
blockade or genetic silencing of T-type Ca
2+
 channels induce a mild and transient ER 
stress that results in the subsequent inhibition of the macroautophagy pathway, probably 
by preventing the autophagosome-lysosome fusion.  This late-stage autophagy inhibition 
is consistent with the mantainance or even upregulation of Atgs like Beclin1 or 
Atg5/Atg12, strong conversion of LC3-II (not further enhanced by Bafilomycin A1) and 
accumulation of p62/SQSTM1. Importantly and, given the fact that the viability of the 
ventricular CMs is not affected in vitro, we propose that such blockade of autophagy 
might be cardioprotective against certain stumuli unleashing an excessive or unspecific 
autophagy. 
  
 
 
 
 
 
 
 
Chapter- 2  
T-type Ca2+ channel blockade 
protects cardiomyocytes 
against hypoxia/re-
oxygenation mediated cell 
death
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1. Introduction 
 
Ischemic heart disease is one of the highly prevalent diseases in the society. Organs and 
cells that depend highly on a continuous supply of oxygen adapt to multiple responses 
against hypoxia or ischemia for their survival. Cardiac cells show a remarkable ability to 
survive hypoxia. Although chronic hypoxia reduces or temporarily stops myocardial 
contractility, the cells can show a full recovery when hypoxia is eased
227
.  Hypoxia, in 
spite of activating a series of cell survival mechanisms, also activates autophagy in the 
myocardium. Amino acids and fatty acids recovered by autophagy are utilized for ATP 
production. In most of the clinical instances, ischemia is followed by spontaneous or 
therapeutic restoration of arterial blood supply termed as reperfusion. Reperfusion also 
elicits a series of cellular responses, including accumulation of reactive oxidative species 
(ROS) and activation of signaling cascades. It has been claimed that the autophagy 
induced during ischemia is further enhanced during reperfusion in the heart in vivo in 
mouse and human heart
143,228
. Cultured neonatal and adult CMs have also been shown to 
experience an enhanced autophagy during ischemia and reperfusion (I/R)
150
.  
Generally speaking, cellular stressors that impair the ability of ER to confer post-
translational changes and lead to ER stress, are potential autophagy inducers
229
. 
Accumulation of unfolded proteins, such as polyglutamine repeat (PolyQ72) in the  ER, 
activates one of the UPR transducers PERK, which in turn induces autophagy to eliminate 
polyQ72 aggregates
172
. ER stress triggered by I/R has been shown to lead to increased 
autophagy in the heart
230
. However, autophagy maintains a complex functional role in I/R 
in the heart. The enhancement and the pathophysiological effects of autophagy could be 
directly proportional to the severity and duration of ischemia and consequent damage 
caused by reperfusion injury in the heart
231
. It has been reported that the enhanced 
autophagy during I/R, involving overexpression of Beclin1, is detrimental for CMs
150
.  
In the pathogenesis of I/R injury, intracellular Ca
2+ 
overload plays an important role
232
. 
Pluteanu and Cribbs reported that T-type Ca
2+
 channels are regulated by 
hypoxia/reoxygenation (H/R) in ventricular myocytes
233
. They also reported that, under 
chronic hypoxic conditions, Cav3.1 mRNA levels decreased (with a subsequent decrease 
in T-type Ca
2+
 channel current density) in a HIF-1α dependent manner. Upon 
reoxygenation, the levels of Cav3.1 mRNA were restored. From the reports of Pluteanu 
and Cribs and Pastukh et al. 
234
., it can be postulated that Cav3.1 channel downregulation 
acts as a protective mechanism to counteract tha Ca
2+
 overload during hypoxia
233-234
. 
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Regarding L-type channels, although a protective effect of L-type Ca
2+
 channel blockers 
from I/R has been demonstrated in a wide variety of experimental models
235
, recently it 
has been reported that the expression of L-type channels either decreased or remained 
unchanged during the I/R episode 
236-237
. As a matter of fact the use of L-type channel 
blockers in humans for myocardial I/R has yielded deceiving results with little or no 
beneficial effects to patients
238
. On the contrary, the T-type channel blocker mibefradil is 
regarded as an effective antiarrythmic compound 
239
 , and is also known to reduce the 
infarct size in adult heart after myocardial infarction 
240-242
. 
Taking into account that hypoxia/reoxygenation induces ER stress and autophagy, in 
addition to the reshuffling of the expression of voltage-gated calcium channels, we aimed 
to characterize these cell responses in our experimental setup, but also to break down the 
effects due to deprivation from those due to hypoxia (which is performed under serum 
deprivation, simulating the blockade of blood flow that characterizes ischemia) or 
reperfusion. The ultimate goal was to check if the pharmacological blockade of T-type 
channels would lead to cardioprotection in a situation of simulated ischemia or 
ischemia/reperfusion by inhibiting an exacerbated autophagy.   
 
2. Results 
 
2.1. Simulated ischemia induces the unfolded-protein response 
 
Compared to the CMs maintained in complete media under normoxic conditions, the 
CMs subject to chronic hypoxia (0,2% O2 for 24 h)  induced a near 2-fold upregulation of 
GRP78 and XBP1, and a 6-fold upregulation of GADD153. Upon reoxygenation for 2-4 
h, the induction of XBP1 and GRP78 was maintained, whereas the levels of GADD153 
dropped below the control levels. Yet, the expression levels of all three UPR markers 
remained considerably below those displayed for CMs deprived from glucose and serum 
and cultured under normoxic conditions.  
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Figure 1: Unfolded protein response induced in the CMs subjected to hypoxia. A) q-PCR 
results show that GRP78 and XBP1 are induced to 1.5-2 fold upon hypoxia as well as 
upon re-oxygenation, whereas GADD153 that was induced by hypoxia to near 6 fold, 
returned to control levels upon re-oxygenation. B) Hypoxia induced a complete splicing 
of XBP1, whereas both forms of XBP1 were reduced by reoxygenation. Both GRP78 and 
GADD153 protein levels were induced by deprivation. Only hypoxia induced an increase 
in GRP78, while it returned to control levels upon reoxygenation. GADD153 was not 
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induced either by hypoxia or reoxygenation and was maintained at control levels. 
Histogram bars represent mean ± SD values from at least 3 independent experiments with 
duplicate measurements of each treatment (n=3). *Significant differences related to 
untreated control, P< 0.05. Western blots are representative of at least 4 consecutive 
experiments. 
 
At the translational level, the expression of GRP78 was also increased by deprivation, 
maintained in hypoxia, and restored to control levels by reoxygenation. The levels of 
GADD153 were also increased by deprivation and restored to control values in CMs 
subject to hypoxia or reoxygenation.  
 
2.2. Simulated ischemia induces autophagy 
 
The expression of Atg genes was analysed for CMs that were maintained in normoxia vs 
hypoxia overnight, and also for those reoxygenated for 4h after hypoxia. Hypoxia and to a 
lesser extent reoxygenation, induced a moderate upregulation of Atg5 and 
downregulation of Beclin1. Following a similar pattern to the one for UPR genes, 
hypoxia and reoxygenation actually counteracted partially (for Atg5) or completely (for 
Beclin1) the deprivation-mediated increases of Atg genes (Figure. 2). 
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Figure 2: Regulation of autophagy markers by ischemia reperfusion. A) q-PCR results 
show that both Atg5 and Beclin1 are induced by deprivation, and that hypoxia and 
reoxygenation bring the levels back to the ones displayed in normoxia (partially for Atg5, 
fully for Beclin1). B) Western blot results show that LC3-II is induced upon deprivation, 
hypoxia and re-oxygenation. Compared to deprivation, hypoxia or re-oxygenation clearly 
decreased the p62/SQSTM1 band intensity, and also the poly-ubiquitinated aggregates. 
The Beclin1 band disappeared with deprivation and hypoxia, whereas reoxygenation 
induced a strong upregulation of Beclin1. The complex Atg5-Atg12 was also reduced by 
deprivation and hypoxia, and increased by reoxygenation. Histogram bars represent 
mean ± SD values from at least 3 independent experiments with duplicate measurements 
of each treatment (n=3). *Significant differences related to untreated control, P< 0.05. 
Western blots are representative of at least 4 consecutive experiments.  
 
At the posttranslational level, we found that deprivation induced the LC3-II conversion, 
which was somewhat mitigated by hypoxia and, especially, reoxygenation. Similarly, 
while deprivation induced an increase in the p62/SQSTM1 levels, hypoxia and 
reoxygenation approached the p62/SQSTM1 band intensity to that from CMs cultured in 
complete media. This result was also supported by the clearance of poly-ubiquitinated 
aggregates by hypoxia and reoxygenation. In an apparent paradox, deprivation and 
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hypoxia suppressed the expression of Beclin1 protein and decreased the formation of the 
Atg5-Atg12 tandem, whereas reoxygenation induced a strong upregulation of both Atg 
proteins.  
 
2.3. Reshuffling of the expression of VGCCs by hypoxia 
 
T-type Cav3.2 channels have been reported to be upregulated under hypoxic conditions in 
different cell types
243-245
, while Cav3.1 has been shown to be downregulated in neonatal 
CMs under sustained hypoxia
233
. 
CMS subjected to deprivation, hypoxia or reoxygenation protocols, including those that 
were pre-conditioned with mibefradil, were analyzed for a putative induction of 
transcripts for VGCCs by q-PCR. We found that deprivation upregulated all T-type 
isoforms including Cav3.1, Cav3.2 and Cav3.3, as well as the L-type channel Cav1.2. 
Hypoxia and reoxygenation alleviated VGCC upregulation, although the values for 
Cav3.3 remained higher than in CMs cultured in serum-containing medium. 
 
 
             
Figure 3: Deprivation significantly raised the mRNA levels for T-type as well as L-type 
calcium channels. The upregulation of all channel isoforms, except of Cav3.3, was largely 
reduced by hypoxia and reoxygenation treatments. Histogram bars represent mean ± SD 
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values from at least 3 independent experiments with duplicate measurements of each 
treatment (n=3). *Significant differences related to untreated control, P< 0.05. 
 
 
However, taking into account that the CMs subject to hypoxia or reoxygenation were also 
maintained in serum and glucose-deprived media most of the time (all of it for the 
hypoxia condition), we can attribute the VGCC channel expression reshuffling to the 
effect of glucose and serum deprivation. In fact, when considering the deprived CMs as 
the bona fide control condition for these experiments, we can conclude that the expression 
of all Ca
2+
 channel isoforms was reduced by both hypoxia and reoxygenation.  
 
2.4. Mibefradil augments cell death induced by hypoxia and mitigates cell death 
induced by reoxygenation 
 
Considering that T-type and L-type Ca
2+
 channels are upregulated under hypoxia and 
reoxygenation compared to control cells grown in rich medium, and that both conditions 
have been reported to decrease the viability of CMs, we pre-conditioned the cells with 
mibefradil for 2h before hypoxia or reoxygenation. We then performed TUNEL assays on 
the cells after hypoxia or reoxygenation, and compared the results with those from cells 
incubated in normoxia (Figure 4).  
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Figure 4: T-type channel blockade confers protection against cell death caused by 
hypoxia/reoxygenation. Deprivation and reoxygenation increased the percentage of tunel 
positive cells significantly. Preconditioning with mibefradil increased the cell death due 
to hypoxia, and, in open contrast, protected against cell death caused by re-oxygenation. 
Histogram bars represent mean ± SD values from at least 3 independent experiments with 
duplicate measurements of each treatment (n=3). *Significant differences related to 
untreated control, P< 0.05. # Significant differences related to deprivation, P<0.05. 
 
We found that as expected deprivation, hypoxia (to a lesser extent) and reoxygenation 
induced the death of CMs. Preconditioning with mibefradil significantly increased the 
percentage of TUNEL positive cells in the cultures subject to hypoxia, whereas, rather 
paradoxically, it decreased the TUNEL positive cells to near control levels in cultures 
subject to reoxygenation.   
 
2.5. T-type channels blockade increased UPR upon ischemia and Reperfusion 
  
Upon preconditioning the cells with the T-type channel blocker mibefradil, hypoxia as 
well as reoxygenation increased the expression of UPR transcripts to the same level or 
even higher than hypoxia or reoxygenation alone (Figure 5A).  
Results and Discussion 
110 
      
 
 
Figure 5: Unfolded Protein Response upon T-type channel blockade under hypoxia and 
reoxygenation conditions. q-PCR data shows that XBP1 and GRP78 expression levels 
under hypoxia and reoxygenation were increased in the presence of mibefradil, whereas 
the level of GADD153 trancripts was grossly maintained. Histogram bars represent mean 
± SD values from at least 3 independent experiments with duplicate measurements of 
each treatment (n=3). *Significant differences related to untreated control, P< 0.05. 
Western blots are representative of at least 3 different experiments. 
 
At the translational level, GRP78 was induced by deprivation and the upregulation was 
maintained in hypoxia, but not in reoxygenation. Mibefradil preconditioning did not 
change the expression of GRP78 in either cells subjected to hypoxia or reoxygenation. 
The GADD153 band was downregulated by hypoxia and re-appeared with mibefradil 
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preconditioning. Although re-oxygenation did not alter the levels of GADD153, under 
mibefradil treatment, re-oxygenation induced the upregulation of GADD153.  
 
2.6. T-type calcium channel blockade altered the expression of Atg genes upon 
hypoxia or reoxygenation 
 
Mibefradil preconditioning upregulated the expression of both Atg5 and Beclin1 
transcripts compared to the cells subjected to hypoxia and reoxygenation (Figure 6A). 
 
 
 
Figure 6: Regulation of autophagy genes by T-type calcium channel blockade under 
hypoxia. A) Application of mibefradil induced the expression of both Atg5 and Beclin1 
genes under hypoxia, while it only induced the expression of Beclin1 upon reoxygenation.  
Histogram bars represent mean ± SD values from at least 3 independent experiments with 
duplicate measurements of each treatment (n=3). *Significant differences related to 
untreated control, P< 0.05. 
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Figure 7: the western blot results show that Beclin1 and Atg5 that were induced by 
reoxygenation were kept near control levels by preconditioning with mibefradil. On the 
other hand, LC3-II was induced by all the experimental conditions. The band 
corresponding to p62/SQSTM1 (top one) was reduced by hypoxia compared to 
deprivation, and restored in the presence of mibefradil. The p62/SQSTM1 levels were not 
increased by reoxygenation, while they were further increased by the presence of 
mibefradil upon reoxygenation. Western blots are representative of at least 3 consecutive 
experiments. 
 
At the protein level, the expression of Atg5 and Beclin1 in hypoxia or reoxygenation was 
reduced to control levels by mibefradil preconditioning. Similarly, both the LC3II/I ratio 
and the p62/SQSTM1 protein levels were increased by mibefradil preconditioning in 
CMs cultured in hypoxia or reoxygenation conditions (Figure.7). 
 
2.7. Assessment of autophagic flux with tandem flagged- LC3 
 
The autophagic flux was further analyzed by overexpression of tandem flagged LC3 
constructs.  
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Figure 8: Autophagic flux assessed by tandem flagged LC3. A) The level of induction of 
autophagy by reoxygenation was much higher than that of the positive control for 
autophagy, rapamycin. Autophagy under deprivation, hypoxia and reoxygenation was 
inhibited by preconditioning with mibefradil. B) The graph shows the percentage of 
yellow and red puncta over the total number of LC3-labelled autophagic vacuoles. The 
high ratio of red over yellow in re-oxygenation was reversed by the addition of 
mibefradil. The lower-level autophagy induced by hypoxia was also blocked by the 
presence of mibefradil. 
 
As a proven inhibitor of the autophagic flux we used the v-ATPase inhibior bafilomycin 
A1, which prevents the fusion of autophagosomes and lysosomes; as expected, 
bafilomycin increased the percentage of yellow puncta (Figure 8). In contrast, rapamycin, 
a known autophagy inducer by inhibiting the mTOR complex-1, increased significantly 
the percentage of red puncta when compared to untreated CMs. We found that the ratio of 
yellow over red puncta was almost 1:1 in CMs cultured in hypoxia, similar to CMs 
cultured in normoxic conditions. However, in the former the total number of puncta was 
largely increased, indictative of autophagy induction
246
. Application of mibefradil under 
hypoxia resulted in inhibition of autophagy which was evident from the increase in the 
ratio of yellow to red puncta up to 9:1.  On the other hand, hypoxia followed by 
subsequent reoxygenation induced a strong autophagic flux by increasing the ratio of red 
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over yellow, while preconditioning with mibefradil induced a drastic reversal of the ratio, 
indicative of a halt in the autophagy flux.  
 
3. Discussion 
 
From the previous chapter, it is clear that the T-type channel blockers can potentially 
inhibit autophagy in CMs. In this study, we examined the effects of T-type channels 
blockade on the CMs homeostatic cell mechanisms and viability, when challenged with 
hypoxia or reoxygenation. 
Initially the presence of transcripts for T- and L-type Ca
2+ 
channels was analyzed in CMs 
that were subjected to chronic hypoxia or reoxygenation. When comparing cells grown in 
rich medium and cells starved from serum and glucose, in normoxic conditions, we could 
appreciate a drastic increase in the expression of L-type Cav1.2 channels, and also of T-
type Cav3.1, Cav3.2 and (to a lesser extent) Cav3.3 channels in the latter. We found that 
neither the expression of Cav3.1 nor of Cav3.2 channels was induced by hypoxia or 
reoxygenation by themselves (Figure 3). In fact and, taking into account that hypoxic and 
reoxygenated cells were also deprived from serum and glucose, we found that all channel 
types were rather downregulated in hypoxia or reoxygenation, when compared to the cells 
that were starved under normoxic conditions, except Cav3.3 For the first time we found 
that Cav3.3 channels, expressed at very low levels in CMs, are upregulated under 
deprivation and that their expression is mantained under hypoxia as well as 
reoxygenation. Pluteanu and Cribbs reported that T-type channel isoforms are 
differentially regulated during ischemia and reperfusion, so that the expression of Cav3.2 
rises and that the expression of Cav3.1 mRNA is lowered, being either levels restored 
upon re-oxygenation 
233
. It has been suggested that T-type channels may act as in vivo 
oxygen sensors, controlling excitability in hypoxic environments
247-248
.  
During hypoxia, Ca
2+
 homeostasis is disrupted through inhibition of 
sarcoplasmic/endoplasmic reticulum Ca
2+
-ATPase pump due to intracellular ATP 
depletion
249
. We found that the mRNA/protein levels of all the three UPR markers were 
upregulated by deprivation (Figure 1), and that they came back to control (rich medium 
and normoxia) values during hypoxia or reoxygenation. In this regard, it had been 
previously reported that ischemia directly activates the ER stress response in the heart by 
inducing one of the UPR branches, ATF6, that in turn triggers the upregulation of 
GRP78
250
. However, upon reperfusion, the ATF6 activity and GRP78 activity are 
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attenuated
251
. It has also been reported that hypoxia induces the AMPK signaling cascade 
possibly HIF-1-mediated, that protects CMs against hypoxic injury by attenuating ER 
stress and apoptotic signals
252-253
. 
.  
Available evidences also indicate that autophagy is induced during ischemia through an 
AMPK-dependent mechanism, whereas reperfusion further enhances autophagy through 
Beclin1 dependent mechanism
143,254
. Matsui et al. reported that autophagy has distinct 
roles during ischemia and reperfusion: while autophagy induced during ischemia might 
be protective, autophagy induced during reperfusion might be detrimental and induce cell 
death. It has been claimed that inhibition of autophagy induced by 3-MA or knockdown 
of Beclin1 led to increase in cell survival in vitro
150
. We observed that deprivation 
increased the levels of Beclin1 and Atg5, concomitantly to an increase in LC3-II and an 
increase in p62/SQSTM1. The levels of p62/SQSTM1 are double edged: on the one hand 
and, as commented earlier, p62/SQSTM1 is a macroautophagy susbtrate and so it is 
degraded faster when the autophagy flux is augmented 
201,208,255
; on the other being 
p62/SQSTM1 an inducible gene, its upregulation has also been related to autophagy 
induction
202
. We also found that, under hypoxia or reoxygenation, the mRNA levels of 
Beclin1 came down to control (rich medium, normoxic) levels, while Atg5 was still 
upregulated in hypoxia. However and, in open contrast, Beclin1 and Atg5-Atg12 protein 
levels were largely decreased by deprivation; these decreases were mantained in cells 
subjected to hypoxia, but not in reoxygenation.  
In apparent consonance with the drop of the Atg5-Atg12 protein levels by deprivation, in 
the light of the level of ubiquitinated aggregates and numbers of autolysosomes 
(monitored by tandem flagged LC3) we could conclude that, under our experimental 
conditions and in the 18-24h time point, deprivation slowed down the autophagic flux and 
that the autophagy process was restarted and shaped by hypoxia or reoxygenation. 
Considering that autophagy induced by reoxygenation is regarded as detrimental, we set 
out to investigate if T-type channel blockade may help in protecting CMs against this type 
of a stimulus, which is the experimental paradigm for ischemia/reperfusion injury. 
Parvinder et al. had suggested that T-type channels are more influential in mediating 
depolarization-evoked Ca
2+
 influx following a period of chronic hypoxia
256
. The viability 
assays performed on the cells exposed to chronic hypoxia followed by reoxygenation may 
indicate that hypoxia acts in a protective manner by reducing cell death induced by 
deprivation, while reoxygenation promotes cell death to a level similar to deprivation 
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(Figure 4). It also regulated the viability of the cells in an opposite manner in hypoxia or 
reoxygenation. Preconditioning with mibefradil in hypoxia induced cell death more than 
hypoxia or even deprivation, whereas preconditioning with mibefradil during H/R 
reduced cell death below the values seen with H/R or deprivation. As a matter of fact, 
mibefradil has been reported to be cardioprotective against ischemia/reperfusion by 
reducing the infarcted area
257
.  It has also been shown that the blockade of ICaT reduces 
both apoptosis and necrosis in CMs under excessive -adrenergic stimulation 258. 
The preconditioning with mibefradil only changed marginally the expression of the 
analyzed UPR or Atg genes in hypoxia or reoxygenation conditions (Figure 6). 
Nonetheless, the p62/SQSTM1 protein levels that had fallen drastically during hypoxia 
were restored by the presence of mibefradil. 
Mibefradil preconditioning during reoxygenation increased both LC3-I and LC3-II bands, 
raising doubts over the autophagic status of the cells.  However, from the overexpression 
of ptf-LC3 constructs, it was clear that the preconditioning was inhibiting the formation 
of autophagosomes (Figure 7). Whereas hypoxia clearly increased the percentage of red 
punta compared to that of deprivation, indicating an increased autophagic flux, mibefradil 
preconditioning increased significantly the percentage of yellow puncta. Similarly, while 
reoxygenation increased the ratio of red over yellow, the application of mibefradil upon 
reoxygenation reversed the ratio, blocking autophagolysosomes formation by an 
estimated 95%.  
In summary, our experiments show that deprivation induces the expression of all VGCC 
channel types in cardiomyocytes, along the development of a strong ER stress that turns 
maladaptive and leads to disruption of the autophagic flux and subsequent cell death. The 
effects of hypoxia per se, probably via the induction of hypoxia-inducible factors, would 
be to restore the levels of VGCCs, downregulate the UPR and restart the autophagic flux. 
In this scenario, the addition of mibefradil in preconditioning treatments would bring the 
cell to a halt in the autophagic flux at a late stage, ultimately jeopardizing the viability of 
the cardiomyocytes. The situation is strikingly different upon reoxygenation. Here, the 
UPR is similar to the one measurable in hypoxia, except for the induction of GADD153. 
The autophagic status, though, is considerably different, as the autophagic flux is very 
much increased in a Beclin1-dependent fashion. In this scenario, mibefradil would favour 
the viability of the CMs by inhibiting an excessive autophagy.  
Results and Discussion 
119 
 
In conclusion and, taking into account that reperfusion after chronic ischemia induces cell 
death by strongly enhancing autophagy in a Beclin1 dependent manner, and that 
preconditioning with mibefradil inhibits the autophagy flux, it can be concluded that de-
regulation of autophagy is a likely cell mechanism through which T-type channel 
blockers exert their cardioprotective actions against ischemia/reperfusion injury. 
 
  
  
 
 
 
 
 
 
 
 
 
Chapter 3  
Cardiac hypertrophy 
mediated regulation of UPR 
and autophagy involves 
upregulation of voltage-gated 
calcium channels.
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1. Introduction 
The deficiency in the capability of the heart to adequately pump blood in response to 
systemic demands results in heart failure. Heart failure is induced by various stimuli such 
as hypertension, myocardial infarction, hypertrophic and dilated cardiomyopathies and 
diabetic cardiomyopathy
259
. Most of the above mentioned stimuli first induce a phase of 
cardiac hypertrophy. A major fraction of the ventricular CMs that is incapable of 
proliferation respond to stress by inducing a hypertrophic growth response. Cardiac 
hypertrophy is characterized by growth in length or width of individual CMs as a means 
of increasing cardiac pump function and decreasing ventricular wall tension and also 
thickening of left ventricular myocardium. Apart from this, a shift in glycolytic 
metabolism, alterations in Ca
2+
 storage and handling, changes in contractility and 
reactivation of a fetal gene program can be observed
162
. Moreover, in the long term, 
cardiac hypertrophy may lead to heart failure, arrhythmia and even sudden death 
260-261
.  
Until now there are no therapeutic agents developed to target directly the hypertrophic 
growth. However, certain strategies are known to alter the hypertrophic growth which 
include suppression of neurohormones release (particularly of catecholamines, 
angiotensinII or aldosterone), Ca
2+
 influx (using Ca
2+
 channel blockers, specifically for L-
type channels) or preload (using vasodilators or diuretics)
262
. Increase in cell mass during 
cardiac hypertrophy means increase in protein synthesis, which is also accompanied by 
structural remodeling and dysfunction of intracellular organelles.  CMs might adapt to 
some cellular mechanisms against structural remodeling due to increase in protein 
synthesis, by inducing autophagy. Autophagy is reported to be activated during the acute 
and chronic phases of cardiac hypertrophy
145,263
. Oyabu et al. has reported that autophagy 
mediated degradation is necessary for hypertrophy regression during ventricular 
unloading
264
. A possible involvement of ER stress has also been reported in models of 
cardiac hypertrophy. Apart from autophagy and ER stress, the altered Ca
2+
 influx through 
T-type channels
222
 
78,265
 and L-type channels
266-267
 are also known to induce cardiac 
hypertrophy.  
We set out to check a possible linkage between cardiac hypertrophy, ER stress, autophagy 
and the VGCCs. We used a selection of cardiac hypertrophy inducers namely angiotensin 
II, aldosterone, phenylephrine (α-adrenergic receptor agonist) and isoprenaline (β-
adrenergic receptor agonist) on cultured neonatal rat ventricular CMs, with the objectives 
of characterizing channel expression, ER-homeostasis and autophagy regulation. Before 
starting these experiments, we realized that most published research works dealing with 
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cardiac hypertrophy in vitro are performed with CMs cultured in serum-free conditions, 
presumably to decrease the chance of growth of any contaminating fibroblasts. On the 
other hand, starvation is a known ER stressor and autophagy inducer in CMs and other 
cell types, and we reasoned that serum deprivation could be inducing some effects that 
would overlap with those due to hypertrophic stimuli.  We consequently performed all the 
experiments both in the absence and presence of serum. 
 
2. Results 
 
2.1. Hypertrophy stimuli induce an increase in the frequency of cell beating 
 
CMs were treated with the hypertrophy stimulants in the absence of serum, namely 
angiotensin II at 100 µM, aldosterone at 1 µM, phenylephrine at 10 µM and isoprenaline 
at 10 µM, 72h after culture. To monitor the induction of cardiac hypertrophy as a 
preliminary screening, the number of cell beats per minute was counted after 48h of 
treatment.  
                         
Figure 1: Hypertrophic stimuli induce a higher cell beating frequency. Histogram bars 
represent mean ± SD values from at least 4 independent experiments with duplicate 
measurements of each treatment (n=4). *Significant differences related to untreated 
control, P< 0.05.    
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All four hypertrophic stimuli induced an increase in the number of beats/minute. Cells 
treated with angiotensin II showed a 2-fold increase in cell beating compared to that of 
untreated control (Figure 1). Aldosterone increased the beating frequency nearly 3-fold, 
phenylephrine 2.5-fold and isoprenaline treated cells showed a 4-fold higher beating 
frequency. A similar pattern of induction of cell beating was also observed in the cells 
treated with the hypertrophy agonists in the presence of serum (data not shown). 
 
2.2.  Hypertrophy markers are induced by the hypertrophy agonists 
 
Natriuretic peptides, namely atrial netriuretic peptide (ANP) and brain natriuretic peptide 
(BNP), are known to be involved in the regulation of cardiac hypertrophy and their 
expression is reported to be induced in angiotensin II- and phenylephrine- induced cardiac 
hypertrophy. Cardiomyocytes that were treated with hypertrophic agonists were analyzed 
for the induction of hypertrophy markers ANP and BNP.  
  
Figure 2: Expression of ANP and BNP in the presence of hypertrophic stimuli. A) A 
moderate expression of ANP and BNP was induced by aldosterone and adrenergic 
agonists (PE and IsP), but not angiotensin II, under serum deprivation.B) Aldosterone 
and adrenergic agonists induced the expression of ANP and BNP in the presence of 
serum. β-actin was used as a house-keeping control. Histogram bars represent mean ± 
SD values from at least 4 independent experiments (n=4). *Significant differences related 
to untreated control, P< 0.05.    
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The exposure to hypertrophic stimuli lasted 48 h and was performed both in the absence 
and presence of serum. The q-PCR data showed a moderate level of induction of the 
genes NPPA and NPPB specifically encoding for ANP and BNP respectively, in the 
presence of aldosterone, phenylepherine and isoprenaline under serum deprivation, and a 
significant level of induction of the same genes in the presence of serum (Figure 2A). In 
contrast, angiotensin II which did not induce any change in either ANP or BNP 
expression in the absence of serum, and induced only a moderate (not significant) 
increase in ANP expression in the presence of serum, while the levels of BNP remained 
the same (Figure 2B). 
 
2.3. Hypertrophic stimuli alter the expression profile of calcium channels 
 
CMS that were treated with the different hypertrophic stimuli where analyzed for 
alterations in the Ca
2+
 channels expression. For this purpose their RNA was extracted, 
and cDNA was retro-transcribed and probed for the genes encoding Cav3.1, Cav3.2, 
Cav3.3 and Cav1.2 channels, in a series of q-PCR assays. 
 
 
 
 
Figure 3: Changes in VGCCs expression upon induction of hypertrophy. A) Hypertrophic 
stimuli alter the expression of VGCCs in the absence of serum.  Except for angiotensin II, 
all the other hypertrophic stimuli used in this study increased the expression of Cav3.2 
and Cav1.2 channels. B) In the presence of serum, angiotensin II moderately increased 
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the expression of all T-type and Cav1.2 L-type channels, while the other hypertrophic 
stimuli induced a significant increase of Cav3.2 and Cav1.2. β- actin was used as a house-
keeping control. Histogram bars represent mean ± SD values from at least 4 independent 
experiments *Significant differences related to untreated control, P< 0.05.    
 
Irrespective of the presence of serum, Cav3.2 mRNA in CMs was induced by 2.5-3-fold 
by aldosterone and 2.2-2.5-fold by isoprenaline. Isoprenaline also enhanced the 
expression of Cav1.2 channels, by nearly 2-fold, in either culturing condition. In 
comparison, phenylephrine increased moderately the levels of Cav3.2 and Cav1.2 mRNA 
in the absence of serum, and only the expression of Cav3.2 in the presence of serum. 
Finally, angiotensin II induced a moderate increase of Cav3.1, Cav3.2 and Cav1.2 only in 
the presence of serum (Figure. 3). 
 
2.4. ER stress mediated by hypertrophic stimuli 
 
Having shown that the hypertrophic stimuli remodel the expression of VGCCs which are 
relevant for Ca
2+
-homeostasis mantainance, we next wondered if hypertrophy was linked 
to the development of ER stress.   
Like in the previous experiments, CMs were treated with the hypertrophic stimuli in the 
presence and absence of serum. The effect of hypertrophic stimuli on the ER homeostasis 
was monitored by analyzing the levels of transcripts from the UPR genes XBP1, GRP78 
and GADD153, with the q-PCR technique. 
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Figure 4: UPR regulation by hypertrophic stimuli. It can be seen that the presence of 
serum enabled the overexpression of UPR markers by hypertrophic stimuli. A) In the 
absence of serum, the hypertrophic stimuli did not induce an increase in any of the UPR 
gene expression, but in fact reduced the expression of GRP78 and GADD153. B) In the 
presence of serum the four hypertrophic stimuli induced the expression of the genes for 
UPR, with phenylephrine and isoprenaline exerting a stronger effect on GRP78 and 
GADD153. β-actin was used as a house-keeping control. Histogram bars represent mean 
± SD values from at least 4 independent experiments *Significant differences related to 
untreated control, P< 0.05.    
 
When the cells were cultured in serum-free media, we observed that none of the 
hypertrophic stimuli induced a significant upregulation of UPR genes (Figure 4A). On the 
contrary, the treatment with all the hypertrophic stimuli except isoprenaline showed a 
down-regulation of the UPR genes GRP78 and GADD153.  The presence of serum in the 
media proved to be determinant for hypertrophic stimuli-mediated ER stress; in this 
condition, angiotensin II, aldosterone and the adrenergic receptor agonists induced the 
expression of GRP78 and GADD153 to varying degrees. 
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Figure 5: Protein expression of UPR markers and XBP1 splicing upon hypertrophic 
stimuli. A) GRP78 levels were increased by all four hypertrophic stimuli in serum free 
conditions, whereas GADD153 level was not altered. B) Under serum deprivation, there 
was no splicing of XBP1 due to any of the hypertrophic stimuli. C) In the presence of 
serum, angiotensin and aldosterone exerted a reduction of the GRP78 levels, whereas the 
expression of GADD153 was increased by all four hypertrophic stimuli. D)  In the 
presence of serum all four hypertrophic stimuli induced splicing of XBP1.  
 
The results were paradoxically different when monitoring the protein levels. Western blot 
experiments for the UPR markers showed that, in the absence of serum, all four 
hypertrophic stimuli increased the intensity of the GRP78 band, while the expression of 
GADD153 remained the same (Figure 5A). On the other hand, the hypertrophic stimuli in 
the presence of serum increased the expression of GADD153, with angiotensin and 
aldosterone additionally downregulating GRP78 expression (Figure 5B).  
The presence of serum also proved to be determinant for hypertrophy-induced XBP1 
splicing: in the absence of serum there was none (Figure 5 B), whereas in the presence of 
serum the splicing of XBP1 was enhanced by the four hypertrophic stimuli (Figure. 5D). 
 
2.5. The Expression of autophagy related genes is altered by hypertrophic stimuli 
 
It is known that autophagy is activated during ventricular hypertrophy. It has also been 
reported that autophagy mediates regression of cardiac hypertrophy during unloading
109
.  
Considering that in CMs cultured in serum-containing medium, the hypertrophic stimuli 
induced ER stress and upregulated the UPR genes, we set out to examine a putative effect 
of the same stimuli on the expression of autophagy related genes.  
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Figure 6: Regulation of ATG genes by hypertrophic stimuli. A) In the absence of serum, 
none of the treatments increased the expression of Beclin1 or Atg5; rather, a trend 
towards a reduced expression of both Atgs was observed. B) In the presence of serum, a 
moderate induction of Beclin1 was observed upon treatment with angiotensin II, 
aldosterone and isoprenaline, as well as a moderate induction of Atg5 by angiotensin II 
and isoprenaline. Neither Beclin1 nor Atg5 mRNA levels were changed by phenylephrine 
treatments. β- actin was used as a house-keeping control  Histogram bars represent mean 
±SD values from at least 4 independent experiments *Significant differences related to 
untreated control, P< 0.05.  
 
In the absence of serum, none of the hypertrophic stimuli increased the expression of 
either Beclin1 or Atg5 (Figure. 6A), but a trend towards a reduced expression could be 
observed. On the contrary, in the presence of serum (Figure. 6A), all the hypertrophic 
stimuli except phenylephrine induced a moderate upregulation of Beclin1, and 
angiotensin II and isoprenaline induced, additionally, a moderate upregulation of Atg5. 
We also studied the expression of autophagy-related genes at the protein level. Western 
blot analysis reflects putative changes in gene induction but also any accompanying post-
transcritptional and post-translational modifications.  
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Figure 7: Protein expression of Atg-related genes upon hypertrophic stimuli under serum 
deprivation. The LC3-II ratio was not increased by any drug and, in fact, aldosterone 
reduced both LC3-I and LC3-II bands. All the stimuli promoted moderate increases of 
Beclin1, Atg5 and Atg5-Atg12. Aldosterone reduced to a minimum the p62/SQSTM1 band 
and limited the accumulation of poly-ubiquitinated aggregates. These western blots are 
representative of at least four independent experiments. 
 
CMs were treated with the four hypertrophic stimuli in the absence of serum. The western 
blot analysis revealed a moderate increase of Beclin1 and Atg5 upon treatment with all 
the hypertrophic stimuli. However, the ratio LC3-II/LC3-I did not increase with any 
treatment; rather it was reduced by aldosterone and ISP (Figure 7). Aldosterone induced a 
decrease of the p62/SQSTM1 band, a result that was in line with the reduction of the 
ubiquitinated protein aggregates. Angiotensin II did not alter the level of p62/SQSTM1, 
whereas phenylephrine and isoprenaline induced the increase of p62/SQSTM1. 
Irrespective of the p62/SQSTM1 levels, angiotensin II, phenylephrine, isoprenaline and 
aldosterone promoted a reduction in ubiquitin aggregates. 
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Figure 8: Protein expression of ATG genes upon hypertrophic stimuli in CMs cultured in 
full-serum culture conditions. Similar to serum free conditions, aldosterone reduced the 
P62/SQSTM1 level which was followed by a reduction in ubiquitin aggregates. Beclin1 
was increased by angiotensin II, aldosterone and phenylephrine, whereas isoprenaline 
promoted a decrease in Beclin1. The Atg5 protein level was reduced by aldosterone, 
phenylephrine and isoprenaline. These western blots are representative of at least four 
independent experiments. 
 
The experiments performed in the presence of serum showed a similar p62/SQSTM1 and 
ubiquitin expression pattern when compared to serum deprived experiments (Figure 8), 
except that angiotensin II increased the p62/SQSTM1 levels. In these conditions, western 
blotting using an antibody against Atg5 did not show significant alterations with Atg5-
Atg12 complex by any of the treatments, whereas Atg5 was reduced by aldosterone, 
phenylephrine and isoprenaline. Nonetheless, angiotensin II and phenylephrine were 
found to increase the level of Beclin1 protein, which was however reduced by 
isoprenaline. In addition, all four treatments performed in the presence of serum increased 
the LC3 II/LC3 I ratio. Similar to the serum-deprived conditions, aldosterone in the 
presence of serum decreased the p62/SQSTM1 level, which was otherwise upregulated by 
angiotensin II, phenylephrine and isoprenaline. However, the ubiquitin results showed a 
decrease in the aggregation of high molecular weight proteins by aldosterone and 
phenyephrine, whereas the levels of these proteins were not altered by angiotensin II and 
isoprenaline. 
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2.6. Hypertrophic stimuli increases autophagic flux 
 
In order to further assess the changes in the autophagic flux induced by the hypertrophic 
stimuli, we transfected the cells with tandem flagged LC3 contructs followed by a 24h 
treatment with the different hypertrophic stimuli.  
Control
Angio
Aldo
PE
ISp
GFP mRFP Merge
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Figure 9: Autophagic flux accessed by tandem flagged LC3. A)  CMs challenged with 
hypertrophic stimuli displayed an increased ratio of yellow over red puncta. B) The graph 
shows the percentage of yellow punta over red puncta. Histogram bars represent mean ± 
SD values from at least 4 independent experiments *Significant differences related to 
untreated control, P< 0.05.    
 
We observed that angiotensin II, aldosterone and the adrenergic agonists, phenylephrine 
and isoprenaline slightly increased the ratio of yellow over red puncta (Figure 9).  
 
3. Discussion 
 
This chapter deals with the involvement of VGCCs in the induction of cardiac 
hypertrophy. It has long been reported that autophagy is induced during cardic 
hypertrophy, and we have earlier showed that both L-type and T-type channel blockers 
de-regulate autophagy in CMs. Thus, this study also intended to elucidate a putative 
involvement of VGCCs in the induction of autophagy upon hypertrophic stimuli.  
Application of the four hypertrophic stimuli increased the cell beating frequency as 
reported earlier. Lalevee et al. reported that aldosterone accelerated spontaneous cell 
contractions by inducing the expression of Cav3.2
268
. They also reported that 
pharmacological blocking of T-type channels with mibefradil, after aldosterone 
stimulation, decreased the cell beating frequency. The other three hypertrophic stimuli, 
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namely angiotensin II, phenylephrine and isoprenaline were also known to increase the 
frequency of cell beating. An increase in cell beating is associated to an increase of the 
cytosolic Ca
2+
 oscillations, which can substantially activate calcineurin/NFAT pathway 
leading to hypertrophic signal
269
.  
We also found that the four drugs used on the CMs in vitro were effective in inducing 
hypertrophy, which was evident from the altered expression of atrial- and brain- 
natriuretic peptides. Both of these natriuretic peptides are synthesized in the heart and are 
essential for cardioprotection. Earlier studies have demonstrated that disruption of 
proANP gene in mice led to hypertension and hypertrophy
270
, and that transgenic 
overexpression of ANP led to protection against hypertrophic stimuli
271
. However, ANP 
and BNP are induced upon progression of hypertrophy. Our results with the hypertrophic 
stimuli showed that three of the drugs namely aldosterone, phenylephrine and 
isoprenaline induced hypertrophic markers both in the presence or absence of serum, 
whereas angiotensin II was successful in inducing hypertrophic markers only in the 
presence of serum.  
Taking into account that Ca
2+
 oscillations are responsible for changes in cell beating 
frequency, and that aldosterone and other stimuli contribute to ventricular arrhythmia, we 
examined the effect of these drugs in the alterations in gene expression of Ca
2+
 channels 
isoforms. Under both culture conditions (serum-containing and serum-free), aldosterone, 
phenylephrine and isoprenaline increased the expression of T-type Cav3.2 and L-type 
Cav1.2 Ca
2+
 channel isoforms. The expression of Cav3.1 was induced by phenylephrine 
and isoprenaline under serum free conditions, and by angiotensin and isoprenaline in the 
presence of serum. β-adrenergic stimulation has previously been reported to increase 
Cav3.1 activity in CMs through the activation of protein kinase A
272
.   
A disruption in Ca
2+
 homeostasis has been reported to be directly responsible for ER 
stress and cardiac remodeling leading to cardiac hypertrophy
273
. Under such conditions of 
ER stress, cytoplasmic Ca
2+
 levels increase leading to the regulation of store operated 
Ca
2+
 entry (SOCE). An increase of cytosolic Ca
2+
, Ca
2+
 release from the ER and 
“rebound” SOCE have been suggested to play an important role in the progression of 
cardiac remodeling and hypertrophy
274
. 
 While the hypertrophic stimuli, in the absence of serum, decreased the levels of UPR 
transcripts in spite of increasing the expression of GRP78 protein the hypertrophic 
stimuli, in the presence of serum, unequivocally upregulated the UPR genes, including 
the splicing of the XBP1 transcription factor. Because serum deprivation is a known 
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inducer of ER stress by itself, the effect of the hypertrophic stimuli on ER stress was 
probably masked in this culture condition. The presence of serum implied opposite effects 
on the regulation of Atg genes as well. Experiments on mouse model of cardiomyopathy 
by Schlossarek et al. had shown that protein levels of autophagosome markers can be 
induced without alterations in mRNA levels, indicative of defective autophagosome 
degradation. However, our western blot results pointed to an induction of autophagy by 
aldosterone, which was evident from the reduced levels of p62/SQSTM1 and subsequent 
clearance of ubiquitinated aggregates, irrespective of the presence or absence of serum.    
On the other hand, angiotensin II, under serum deprivation, did not induce a change in the 
p62/SQSTM1 levels, but increased the clearance of poly-ubiquitinated protein aggregates. 
Similarly, in the presence of serum, although angiotensin II, phenylephrine and 
isoprenaline induced an increase in the p62/SQSTM1 levels, they also induced a 
clearance of poly-ubiquitinated aggregates. The linkage between p62/SQSTM1 and 
autophagic flux is not straightforward: proteotoxicity resulting from the increased 
expression of misfolded/damaged proteins lead to cardiac proteosome functional 
insufficiency, which in turn upregulated p62/SQSTM1 and triggered compensatory 
autophagy
275-276
.  Also, pharmacological inhibition of proteosomal activity has been 
reported to increase the expression of p62/SQSTM1 
277-278
. In addition, Zheng et al have 
shown that p62/SQSTM1 and macroautophagy are concurrently upregulated in DRC 
mouse hearts
202
. Apart from that, p62/SQSTM1 has been reported to control its own 
expression by NRF2 activation regulation
279
.  
In addition to booster the removal of poly-ubiquitinated proteins, the hypertrophy-
inducing drugs except phenylephrine increased the green/yellow over the red puncta in 
CMs transfected with ptf-LC3 constructs, a result which is compatible with inhibition of 
the autophagic flux, adding to confusion. 
Although, as mentioned earlier, there are a few reports suggesting that autophagy is 
induced during cardiac hypertrophy, Nakai et al. reported that autophagy is not essential 
for cardiac hypertrophy induced by various stressors including angiotensin II 
159
; they 
also reported that inhibition of autophagy led to the development of cardiac hypetrophy. 
Also, Oyabu et al. have recently reported, using a pressure-overload induced mice model, 
that autophagy is involved in the regression of pressure-overload induced cardiac 
hypertrophy
264
. Taking our own results and published (contradictory) data together, it is 
evident that the molecular mechanisms underlying autophagic regulation by cardiac 
hypertrophy have not been clearly elucidated.  
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In an attempt to reconcile discrepancies and, as a matter of speculation, we put forward 
the hypothesis that forms of protein degradation other than macroautophagy, i.e. 
chaperone-mediated autophagy, and/or the activation of the ubiquitin proteasome system, 
are involved in the adaptation of CMs to hypertrophic insults. Such compensatory 
mechanisms would be triggered in response to a decreased autophagic flux during the 
initial, anabolic phase of hypertrophy.        
In conclusion, our data shows that hypertrophy involves the upregulation of both L-type 
and T-type Ca
2+
 channels, although different stimuli display qualitative and quantitative 
differences regarding the induction of channel isoforms; it also shows that ER stress is a 
consequence of all hypertrophic stimuli, although it is masked by culturing the cells under 
serum deprivation; finally, it is inconclusive regarding the autophagic status of the CMs 
exposed to hypertrophic insults, irrespective of the culture conditions, as mentioned a few 
lines above. Nonetheless, the fact that T-type channels, which are expressed during the 
embryonic stages and dissapear during the neonatal development, reappear under 
pathological cardiac hypertrophy, strongly encourages the screening of T-type channel 
blockers to tackle the late-phase remodeling that anticipates heart failure and that is 
unmistakenly associated with an exacerbated autophagy
280
. 
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Conclusion 
 
1. L-type, but not T-type calcium channel pharmacological blockers, induce the 
apoptotic death of in vitro-cultured neonatal CMs. 
 
2. Both T-type and L-type calcium channel blockers promote a transitory cellular ER 
stress response, which can be monitored through the upregulation of 3 key actors 
of the unfolded protein response (UPR). 
 
3. T-type channel, but not L-type channel blockers, induce the splicing of XBP1 into 
its transcriptionally active form. 
 
4. L-type calcium channel blockers increase the basally strong autophagic flux in 
CMs, whereas T-type channel blockers exert the opposite effect and inhibit 
autophagy by preventing the formation of autophagolysosomes.  
 
5. Gene knockdown of the T-type channel isoform Cav3.2 by the siRNA approach 
activates the UPR and inhibits the constitutive macroautophagy of CMs, thus 
mimicking the effects of T-type calcium channel blockers. However, the 
knockdown of the L-type channel isoform Cav1.2 mimicks the effects of T-type 
channel blockers too. 
 
6. The expression of the different voltage-gated calcium channel isoforms is inter-
related, such that the silencing of Cav3.1 is concomitant to the upregulation of 
Cav3.2, and the knockdown of both Cav1.2 and Cav1.3 channels is linked to the 
upregulation of both T-type channel isoforms (predominantly Cav3.1). 
 
 
7. Serum and glucose deprivation induce ER sress and an Unfolded Protein 
Response characterized by induction of GRP78 and GADD153 genes. However, 
when deprived cells are subjected to chronic hypoxia (0.2% O2 for 18-24h) as an 
in vitro paradigm of chronic ischemia, the expression of GRP78 and GADD153 is 
reduced, and the splicing of XBP1 is induced. Upon reoxygenation (an in vitro 
paradigm of ischemia/reperfusion) the levels of XB1s return to control values.   
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8. Serum and glucose deprivation for 24 h deregulate autophagy in CMs in a 
complex manner: increasing the transcripts for Atg5 and Beclin1 but reducing 
their protein levels. Chronic hypoxia and reoxygenation attenuate deprivation-
induced changes in Atgs expression and, particularly reoxygenation, increase the 
level of Beclin1 protein above control. Putting together Atg expression and the 
analysis of the autophagic flux, we conclude that hypoxia increase moderately and 
reoxygenation increase drastically macroautophagy, which is reduced by 
deprivation. 
 
9. Serum and glucose deprivation increase the percentage of tunel positive CMs, 
indicative of apoptosis. Hypoxia protect against deprivation-induced cell death to 
some extent, whereas reoxygenation increase cell death above deprivation.  
10. Serum and glucose deprivation induce the transcription of all analyzed VGCC 
channel types in CMs, including the three T-type channel isoforms. Hypoxia 
normalizes the expression of VGCCs to great extent, and reoxygenation does not 
involve further changes compared to hypoxia. 
 
11. Preconditioning with the T-type channel blocker mibefradil reduces the 
autophagic flux present in CMs subjected to hypoxia or reoxygenation. 
 
12. Preconditioning with mibefradil increases the death of CMs by hypoxia, but 
decreases the death of CMs by reoxygenation.  
 
13. Application of four functionally different hypertrophic stimuli enhances the 
contractility and increases the expression of two hypertrophic markers ANP and 
BNP in CMs cultured in vitro. 
  
14. Specific isoforms of L-type and T-type calcium channel are upregulated in CMs 
by the four functionally different hypertrophic stimuli, to varying degrees. 
 
15. In the absence of serum in the culture medium, the UPR markers in CMs are 
decreased by the four hypertrophic stimuli, as serum deprivation is a UPR inducer 
Conclusions 
143 
 
by itself. In the presence of serum, the four hypertrophic stimuli upregulate UPR 
markers to some extent. 
 
16. The different hypertrophic stimuli exert distinct effects on Atg transcripts and 
proteins, and on p62/SQSTM1 levels. Nevertheless, they all coincide in reducing 
the autophagic flux from the viewpoint of tandem-fluorescent LC3, while 
increasing the clearance of poly-ubiquitinated aggregates. We thus conclude that, 
in the initial stages of hypertrophic insults, the macroautophagy in CMs is 
reduced. In turn, this feature unleashes compensatory mechanisms in the shape of 
alternative forms of autophagy and/or augmented proteasomal degradation.  
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Conclusiones 
 
1. Los bloqueantes farmacológicos de canales de tipo L, pero no los de tipo T, inducen 
la muerte apoptótica de los cardiomiocitos neonatales cultivados in vitro 
 
2. Los bloqueantes de canales de tipo L y T promueven un estrés de retículo transitorio, 
que monitorizamos a través de la sobre-regulación de 3 actores clave de la respuesta 
UPR: la chaperona molecular GRP78, el regulador transcripcional XBP1 y el factor 
de transcripción GADD153.  
 
3. Los bloqueantes de canals de tipo T, pero no los de tipo L, inducen el procesamiento 
de XBP1 hasta una forma transcripcionalmente activa. 
 
4. Los bloqueantes de canales de tipo L aumentan el flujo autofágico basal en los 
cardiomiocitos, mientras que los bloqueantes de de canales de tipo T  ejercen el efecto 
contrario e  inhiben la autofagia previniendo la formación de autofagolisosomas.  
 
5. El silencimiento génico de la isoforma Cav3.2 mediante la aproximación del siRNA 
activa la UPR e inhibe la macroautofagia constitutiva de los cardiomiocitos, 
mimetizando así los efectos de  los bloqueantes de canales de tipo T. No obstante, el 
silenciamiento de la isoforma Cav1.2 también mimetiza los efectos de los bloqueantes 
de canales de tipo T. 
 
6. La expression de los distintos tipos de canals de calcio voltaje-dependientes está inter-
relacionada, de modo que el silenciamiento de Cav3.1 es concomitante a la sobre-
regulación de Cav3.2, y el silenciamiento de Cav1.2 y Cav1.3 se asocia con la sobre-
regulación de ambas isoformas de canales de tipo T (aunque predominantemente de 
Cav3.1). 
 
 
7. La deprivación de suero y glucose induce estrés de retículo y una respuesta UPR 
caracterizada por la inducción de GRP78 y GADD153. No obstante, cuando las 
células deprivadas se someten a hipoxia crónica (0.2% O2 durante 18-24h) como 
paradigm in vitro de isquemia crónica, se reduce la expresión de GRP78 y GADD153 
y aumenta el procesamiento postranscripcional de XBP1. Cuando los cardiomiocitos 
Conclusions 
145 
 
son reoxigenados (un paradigm in vitro de la isquemia/reperfusión) los niveles de 
XBP1s se reducen hasta los valores control.   
 
8. La deprivación de suero y glucosa durante 24 h desregula la autofagia en los 
cardiomiocitos de una forma compleja: incrementa el mARN para Atg5 y Beclin1 y, 
no obstante, reduce los respectivos niveles de proteína. La hypoxia crónica y la 
reoxigenación atenuan los cambios en la expresión de Atgs inducidos por la 
deprivación y, particularmente la reoxigenación, incrementó los niveles de Beclin1 
proteína por encima de los niveles control. Al considerar la expression de Atg y el 
análisis del flujo autofágico, concluímos que la hypoxia incrementa moderadamente y 
la reoxigenación drásticamente la macroautofagia inhibida por la deprivación. 
 
9. Serum and glucose deprivation increased the percentage of tunel positive 
cardiomyocytes, indicative of apoptosis. Hypoxia protected against deprivation-
induced cell death to some extent, whereas reoxygenation increased cell death above 
deprivation.  
10. La deprivación de suero y glucosa induce la transcripción de todos los tipos de 
canales de calcio voltaje-dependientes analizados, incluyendo las 3 isoformas de 
canales de tipo T. La hipoxia tiende a normalizar la expresión de los canales, y la 
reoxigenación no implica cambios respecto a la hipoxia. 
 
11. El precondicionamiento con el bloqueante de canales de tipo T mibefradil reduce el 
flujo autofágico presente en cardiomiocitos sometidos a hipoxia o reoxigenación. 
 
12. El precondicionamiento con mibefradil incrementa la muerte de los cardiomiocitos 
debida a la hipoxia, pero redúce la muerte de los cardiomiocitos debida a la 
reoxigenación.  
 
13. La aplicación de 4 estímulos hipertróficos funcionalmente distintos aumenta la 
contractilidad e incrementa la expresión de los marcadores de hipertrofia ANP and 
BNP en cardiomiocitos. 
  
14. Los 4 estímulos hipertróficos sobre-regulan la expresión de isoformas específicas de 
canales de tipo L y T in vitro, en grado variable. 
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15. En la ausencia de suero en el medio de cultivo los estímulos hipertróficos disminuyen 
los marcadores de UPR en los cardiomiocitos, debido a que la deprivación de suero es 
un inductor de UPR por si misma. En la presencia de suero los 4 estímulos 
hipertróficos sobreregularon los marcadores UPR en grado variable. 
 
16. Los distintos estímulos hipertróficos ejercen efectos diferenciales sobre los tránscritos 
y las proteínas de Atg, y sobre los niveles de proteína p62, aunque todos ellos reducen 
el flujo autofágico medido a través de tf-LC3, mientras que aumentan la degradación 
de los agregados poli-ubicuitinizados. Por ello concluímos que, en los estadios 
iniciales del estímulo hipertrófico, en los que predominan las vías anabólicas, se 
reduce de forma concomitante la macroautofagia; no obstante, ello desencadena 
mecanismos compensatorios a través de la activación de formas alternativas de 
autofagia y/o de un aumento de la degradación proteasomal. 
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